rfhg_97865.1

Basic information about the TSS

---

TSS ID: rfhg_97865.1 Species: human Chr: chr7		Start: 101212562 End: 101212585 Strand: -
Source datasets	FANTOM5
Protocol	CAGE
TSS cluster detected*	1

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	-
Category:	-

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: ENST00000460475.1:-391 GeneID: 8985 HGNC/MGI_ID: HGNC:9083 UniProt_ID: Nearer transcript ids and distances:

Gene_name: procollagen-lysine,2-oxoglutarate 5-dioxygenase 3 Gene_symbol: PLOD3 Gene_synonyms: LH3 Gene_source: HGNC:9083

TATA-Box annotation

---

Distance to TSS:	5008
Nearest PromoterID:	NM_001084
Entrez ID:	8985
Nearest Unigene:	Hs.153357
Nearest Refseq:	NM_001084
Nearest Ensembl:	ENSG00000106397
Gene Name:	procollagen-lysine,2-oxoglutarate 5-dioxygenase 3
Gene Alias:	LH3
Gene Type:	protein-coding
CpG%:	0.000000
GC%:	0.625000
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@PLOD3 p2@PLOD3 p3@PLOD3 p4@PLOD3 p5@PLOD3 p6@PLOD3 p7@PLOD3 p8@PLOD3 p9@PLOD3
Sample		p1@PLOD3	p2@PLOD3	p3@PLOD3	p4@PLOD3	p5@PLOD3	p6@PLOD3	p7@PLOD3	p8@PLOD3	p9@PLOD3
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	17.53	0.78	1.56	0.19	0.00	0.00	0.00	0.00	0.00
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	19.42	0.20	2.63	0.20	0.40	0.00	0.40	0.00	0.20
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	16.01	0.39	2.12	0.00	0.00	0.19	0.00	0.00	0.00
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	14.97	0.00	2.29	0.00	0.00	0.00	0.21	0.00	0.00
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	16.42	0.45	1.57	0.00	0.22	0.00	0.00	0.00	0.00
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	14.54	0.58	2.13	0.58	0.00	0.19	0.39	0.00	0.00
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	22.22	0.44	2.61	0.22	0.44	0.22	0.00	0.00	0.22
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	15.99	0.48	2.18	0.48	0.00	0.24	0.00	0.00	0.00
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	13.04	0.43	2.56	0.00	0.21	0.00	0.21	0.00	0.00
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	22.03	1.16	4.64	0.58	0.00	0.58	0.00	0.00	0.00
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	18.59	1.62	3.64	0.00	0.40	0.40	0.00	0.00	0.40
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	17.89	0.41	4.07	0.00	0.00	0.00	0.00	0.00	0.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	44.97	4.67	4.35	0.16	0.32	0.00	0.00	0.32	0.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	29.47	3.91	3.76	0.00	0.45	0.15	0.15	0.15	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	35.79	4.17	4.17	0.00	0.22	0.00	0.00	0.00	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	34.20	3.77	4.78	0.00	0.00	0.00	0.25	0.25	0.25
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	32.11	4.37	5.90	0.00	0.22	0.22	0.00	0.00	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	31.64	2.95	3.37	0.42	0.00	0.00	1.27	0.00	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	32.52	2.13	5.86	0.00	0.00	0.53	0.00	0.00	0.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	32.34	3.76	4.21	0.00	0.30	0.15	0.15	0.30	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	32.34	5.48	6.15	0.27	0.00	0.27	0.40	0.13	0.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	30.04	5.70	3.63	0.35	0.17	0.17	0.17	0.17	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	28.82	4.14	5.17	0.39	0.26	0.00	0.00	0.13	0.39
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	31.55	3.88	3.40	0.49	0.24	0.24	0.49	0.24	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	32.51	5.16	4.13	0.52	0.52	0.00	0.00	0.26	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	40.20	4.43	4.43	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	40.11	6.04	3.30	0.00	0.00	1.10	1.10	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	39.37	6.13	4.95	0.00	0.24	0.00	0.00	0.00	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	31.34	3.55	4.36	0.48	0.16	0.00	0.16	0.00	0.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	25.15	5.25	3.08	0.18	0.00	0.00	0.00	0.00	0.54
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	34.75	5.65	5.86	0.21	0.00	0.00	0.21	0.00	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	27.35	5.08	4.88	0.00	0.59	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	30.60	6.33	5.28	0.42	0.42	0.21	0.00	0.00	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	25.40	3.13	3.63	0.33	0.33	0.00	0.33	0.00	0.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	29.73	3.93	3.18	0.19	0.19	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	26.64	4.98	4.98	0.19	0.57	0.00	0.00	0.00	0.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	28.61	5.11	4.29	0.20	0.20	0.41	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	27.60	4.43	3.02	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	28.36	5.67	4.32	0.27	0.27	0.00	0.00	0.00	0.54
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	24.01	5.76	4.08	0.24	0.24	0.00	0.00	0.00	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	24.94	5.18	6.59	0.00	0.24	0.00	0.00	0.00	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	21.08	4.39	4.83	0.00	0.44	0.44	0.15	0.44	0.29
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	28.26	5.69	6.12	0.00	0.21	0.00	0.00	0.00	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	33.74	5.07	5.42	0.35	0.17	0.00	0.17	0.35	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	26.90	5.22	5.22	0.40	0.60	0.00	0.40	0.00	0.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	30.24	6.28	3.49	0.23	0.23	0.23	0.00	0.23	0.23
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	32.39	8.64	6.96	0.24	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	31.00	5.96	8.05	0.30	0.89	0.00	0.30	0.30	0.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	30.16	7.66	5.51	0.48	0.48	0.00	0.00	0.00	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	29.93	6.87	6.67	0.00	0.00	0.20	0.20	0.00	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	31.77	4.10	7.79	0.20	0.41	0.00	0.00	0.00	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	36.25	7.12	10.90	0.00	0.00	0.00	0.00	0.00	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	27.98	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	19.16	9.23	4.26	0.00	0.00	0.00	0.00	0.00	1.06
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	15.58	7.29	8.28	0.00	0.00	0.00	0.00	0.33	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	25.17	1.68	2.52	0.00	0.84	0.00	0.00	0.00	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	25.26	3.67	4.13	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	21.72	6.81	6.16	0.00	0.32	0.32	0.32	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	17.02	9.31	7.39	0.32	0.32	0.00	1.28	0.00	0.64
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	27.03	5.66	5.03	0.94	0.00	0.00	0.31	0.00	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	16.22	13.40	6.35	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	18.51	7.29	5.05	0.56	0.00	0.00	0.00	0.00	1.12
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	50.95	7.96	3.98	0.00	0.80	0.00	0.80	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	26.84	5.78	10.53	0.34	1.02	0.34	0.00	0.34	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	31.52	15.27	11.70	1.62	0.00	0.00	0.00	0.00	2.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	22.36	16.33	8.16	1.06	0.35	0.35	0.00	0.00	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	16.16	0.00	16.16	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	55.28	7.90	7.90	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	30.71	27.79	7.31	1.95	0.00	0.00	0.98	0.00	1.46
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	23.31	17.36	8.43	0.00	0.00	0.00	0.99	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	25.80	15.48	8.91	0.47	0.00	0.47	0.00	0.00	1.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	50.01	15.57	14.90	1.66	0.00	0.00	0.33	0.33	1.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	32.17	18.87	10.52	0.62	0.31	0.31	0.62	0.62	0.93
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	31.49	19.57	13.15	0.92	0.00	0.00	0.31	0.61	0.31
Adipocyte - breast, donor1	11376-118A8	41.02	26.93	7.76	0.79	0.63	0.63	0.48	0.16	0.00
Adipocyte - breast, donor2	11327-117E4	46.04	18.93	4.01	0.32	0.80	0.16	0.80	0.16	0.16
Adipocyte - omental, donor1	11473-119C6	40.84	24.55	9.03	0.51	0.51	0.25	0.64	0.13	0.51
Adipocyte - omental, donor2	11474-119C7	31.39	14.20	1.49	0.75	0.75	0.00	0.00	0.00	0.00
Adipocyte - omental, donor3	11475-119C8	27.80	20.43	7.70	0.33	0.67	0.00	1.00	0.00	0.67
Adipocyte - perirenal, donor1	11476-119C9	22.33	19.78	7.02	1.28	0.00	0.00	1.28	0.00	0.64
Adipocyte - subcutaneous, donor1	11259-116F8	23.09	3.30	4.40	0.00	0.00	1.10	0.00	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	36.58	10.39	2.26	0.00	0.00	0.45	0.45	0.00	0.90
Adipocyte - subcutaneous, donor3	11408-118E4	28.85	4.52	1.39	0.00	0.00	0.17	0.87	0.00	0.17
Adipocyte differentiation, day04, donor1	13019-139D4	44.39	6.85	6.06	0.20	0.78	0.20	0.00	0.00	0.00
Adipocyte differentiation, day04, donor2	13022-139D7	34.49	4.38	4.89	0.51	0.51	0.00	0.00	0.00	0.51
Adipocyte differentiation, day04, donor3	13025-139E1	47.67	10.59	5.02	0.00	0.28	0.00	0.28	0.28	0.28
Adipocyte differentiation, day04, donor4	13028-139E4	48.79	4.70	10.58	0.00	0.59	0.00	0.00	0.00	0.59
Adipocyte differentiation, day08, donor1	13020-139D5	33.38	4.75	3.22	0.16	0.56	0.08	0.16	0.08	0.24
Adipocyte differentiation, day08, donor2	13023-139D8	31.31	5.16	2.90	0.32	0.32	0.00	0.32	0.00	0.00
Adipocyte differentiation, day08, donor3	13026-139E2	27.19	8.00	4.27	0.00	0.53	0.00	0.00	0.00	0.53
Adipocyte differentiation, day08, donor4	13029-139E5	25.04	5.01	2.23	0.56	0.00	0.00	0.00	0.00	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	24.12	3.74	2.50	0.42	0.00	0.00	0.42	0.00	0.00
Adipocyte differentiation, day12, donor2	13024-139D9	33.66	4.77	3.27	0.00	0.25	0.00	0.00	0.00	0.00
Adipocyte differentiation, day12, donor3	13027-139E3	26.83	6.22	3.60	0.00	0.33	0.00	0.65	0.33	0.33
Adipocyte differentiation, day12, donor4	13030-139E6	20.10	4.87	1.83	0.61	0.61	0.00	0.00	0.00	0.30
Alveolar Epithelial Cells, donor1	11510-119G7	37.57	18.34	10.17	0.22	0.66	0.22	0.44	0.00	0.44
Alveolar Epithelial Cells, donor2	11590-120G6	36.58	17.93	10.40	1.43	1.43	0.36	0.36	0.00	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	37.14	10.78	4.79	1.20	0.00	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	26.45	13.13	5.40	0.36	0.36	0.18	0.00	0.00	0.00
Amniotic Epithelial Cells, donor2	11613-122A2	50.20	16.73	3.35	0.00	0.00	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	35.13	19.31	4.73	0.82	0.41	0.00	0.41	0.00	0.41
Anulus Pulposus Cell, donor1	11248-116E6	23.80	11.56	5.26	0.00	0.23	0.11	0.23	0.00	0.11
Anulus Pulposus Cell, donor2	11463-119B5	15.43	8.57	2.69	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	35.05	9.44	7.19	0.90	0.90	0.45	0.45	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	27.35	11.72	6.95	0.87	0.87	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	42.80	12.84	2.14	2.14	0.00	0.00	0.00	2.14	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	31.98	13.15	7.47	0.30	0.00	0.00	0.30	0.00	0.90
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	22.76	18.97	2.53	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	34.32	13.20	3.96	0.66	1.32	0.00	0.00	0.00	1.32
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	26.32	12.35	5.52	0.32	0.32	0.32	0.32	0.00	0.65
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	30.10	11.65	3.88	0.00	0.00	0.00	0.49	0.00	0.97
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	25.54	17.82	2.97	2.38	1.19	0.00	0.59	0.00	0.59
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	29.75	11.68	6.03	0.38	0.75	0.00	0.00	0.00	0.75
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	23.22	11.61	5.08	0.73	0.73	0.00	0.00	0.00	0.73
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	43.88	13.79	10.03	0.00	0.00	1.25	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	34.92	17.63	6.59	1.15	0.49	0.00	0.00	0.00	0.33
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	21.84	16.38	13.65	1.36	1.36	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	22.62	11.61	5.88	0.60	0.15	0.00	0.00	0.00	0.15
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	33.22	9.64	6.43	0.00	1.61	0.00	1.07	0.00	1.61
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	30.04	14.36	5.29	0.57	0.19	0.00	0.19	0.19	0.76
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	35.82	20.85	6.95	0.00	0.80	0.00	0.27	0.00	0.80
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	24.39	12.68	2.93	0.00	0.00	0.00	0.00	0.00	1.95
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	25.21	12.77	3.81	0.50	0.50	0.17	0.17	0.00	0.66
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	25.22	9.61	2.40	0.00	1.20	0.00	1.20	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	38.94	17.70	10.62	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	28.82	14.24	4.63	0.34	0.34	0.00	0.17	0.00	0.17
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	37.75	25.17	8.39	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	29.61	13.59	2.91	0.00	0.00	0.00	0.00	0.00	0.97
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	33.01	13.66	6.83	0.00	0.00	0.38	0.38	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	37.55	12.11	4.85	0.00	0.00	1.21	1.21	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	38.19	12.54	5.13	0.57	0.57	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	30.36	14.54	5.34	0.43	0.21	0.64	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	31.75	11.61	5.42	0.52	0.00	0.00	0.26	0.52	0.26
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	31.44	11.26	6.10	0.00	0.47	0.00	0.00	0.00	0.94
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	30.55	11.25	6.43	0.32	0.32	0.00	0.00	0.00	0.64
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	35.67	11.42	4.99	0.00	0.71	0.00	0.71	0.71	0.71
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	35.68	8.19	5.26	0.00	0.00	0.00	0.00	0.58	0.58
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	26.19	16.56	7.23	0.30	0.60	0.30	0.00	0.00	1.20
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	24.95	19.01	7.13	0.00	0.00	1.19	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	31.53	13.73	5.09	0.00	0.00	0.00	1.02	0.51	2.03
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	32.60	15.28	4.84	0.00	0.51	0.51	0.25	0.00	1.02
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	26.69	10.17	1.91	0.64	0.64	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	25.89	13.38	7.34	0.00	0.00	0.43	0.00	0.00	0.86
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	28.15	12.91	4.23	0.42	0.21	0.00	0.42	0.00	0.21
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	26.97	16.82	5.51	0.00	0.00	0.00	0.58	0.00	0.29
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	30.23	14.17	5.67	0.00	0.00	0.00	0.94	0.00	0.94
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	27.12	12.04	4.24	0.51	0.34	0.34	0.00	0.00	0.34
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	18.53	6.95	2.32	2.32	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	25.35	10.56	4.23	2.11	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	28.09	14.37	7.50	0.86	1.07	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	27.68	19.85	8.42	0.60	0.60	0.00	0.00	0.00	1.20
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	21.87	13.85	5.10	0.73	0.73	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	28.05	15.17	8.74	0.69	0.23	0.46	0.46	0.00	0.23
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	33.15	10.20	7.65	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	30.25	13.73	5.08	0.76	0.25	0.00	0.00	0.00	0.76
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	30.55	13.21	5.57	0.83	0.21	0.00	0.00	0.00	0.83
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	33.05	14.69	3.98	0.61	0.31	0.00	0.00	0.00	0.61
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	38.24	13.86	6.69	1.43	0.48	0.48	0.48	0.00	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	23.73	12.86	2.66	0.22	0.22	0.00	0.67	0.44	0.89
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	28.99	15.26	4.58	1.53	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	24.37	11.63	2.77	0.55	1.11	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	30.72	15.36	6.62	0.53	0.26	0.00	0.26	0.00	0.79
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	30.53	16.72	6.54	0.73	0.00	0.36	0.36	0.00	0.36
Astrocyte - cerebellum, donor1	11500-119F6	46.92	10.56	11.91	0.61	0.25	0.00	0.12	0.00	0.12
Astrocyte - cerebellum, donor2	11580-120F5	40.22	10.78	10.10	0.51	0.17	0.17	0.00	0.00	0.51
Astrocyte - cerebellum, donor3	11661-122F5	43.84	7.76	7.76	0.21	0.42	0.00	0.00	0.21	0.21
Astrocyte - cerebral cortex, donor1	11235-116D2	21.96	3.49	1.74	0.35	0.00	0.00	0.00	0.00	0.00
Astrocyte - cerebral cortex, donor2	11316-117D2	35.91	4.21	4.21	0.49	0.49	0.00	0.16	0.00	0.00
Astrocyte - cerebral cortex, donor3	11392-118C6	34.46	6.71	5.82	0.45	0.45	0.30	0.15	0.00	0.30
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	25.57	0.80	0.69	0.11	0.11	0.00	0.00	0.11	0.00
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	23.93	0.75	0.75	0.00	0.00	0.00	0.00	0.00	0.00
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	21.74	1.14	0.34	0.00	0.11	0.00	0.00	0.00	0.00
Basophils, donor1	12241-129G9	17.00	2.35	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Basophils, donor2	12242-129H1	16.96	5.41	0.36	0.00	0.00	0.00	0.00	0.00	0.00
Basophils, donor3	12243-129H2	15.88	2.06	1.18	0.00	0.29	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor1	11511-119G8	18.11	6.04	3.02	0.00	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor2	11591-120G7	28.35	17.37	8.23	0.46	0.00	0.00	0.00	0.46	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	14.35	21.52	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	19.46	8.79	4.39	0.00	0.00	0.00	0.00	0.63	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	19.96	7.69	3.54	0.00	0.42	0.00	0.00	0.00	0.42
Bronchial Epithelial Cell, donor6	11461-119B3	20.96	5.53	3.68	0.23	0.23	0.00	0.00	0.00	0.23
Bronchial Epithelial Cell, donor7	11769-123I5	17.63	5.76	3.06	0.00	0.00	0.00	0.36	0.00	0.00
Burkitt's lymphoma cell line:DAUDI	10422-106C8	3.50	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Burkitt's lymphoma cell line:RAJI	10476-106I8	12.58	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	21.42	1.92	0.96	0.00	0.00	0.00	0.00	0.00	0.00
CD133+ stem cells - cord blood derived, pool1	12223-129E9	20.68	10.34	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	11.83	2.82	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor2	11305-117B9	16.15	3.53	0.56	0.00	0.19	0.19	0.19	0.00	0.00
CD14+ Monocytes, donor3	11381-118B4	14.71	2.41	0.88	0.00	0.44	0.00	0.22	0.22	0.00
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	46.42	6.23	3.40	0.00	0.00	0.28	0.57	0.28	0.28
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	49.66	7.58	5.69	0.00	0.76	0.00	0.38	0.00	0.38
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	48.65	7.23	5.92	0.00	0.00	0.00	0.00	0.33	0.00
CD14+ monocytes - mock treated, donor1	11863-125A9	18.07	4.05	1.88	0.14	0.72	0.00	0.14	0.00	0.14
CD14+ monocytes - mock treated, donor2	11873-125C1	16.60	2.41	2.41	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - mock treated, donor3	11883-125D2	15.63	2.13	1.66	0.00	0.24	0.00	0.00	0.24	0.47
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	12.39	2.68	1.84	0.00	0.17	0.00	0.00	0.00	0.17
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	11.87	1.38	0.83	0.00	0.28	0.00	0.28	0.00	0.00
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	13.88	1.98	0.99	0.00	0.00	0.00	0.00	0.00	0.25
CD14+ monocytes - treated with BCG, donor1	11860-125A6	12.92	1.76	0.98	0.00	0.00	0.00	0.39	0.00	0.00
CD14+ monocytes - treated with BCG, donor2	11870-125B7	12.11	0.36	0.89	0.00	0.53	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with BCG, donor3	11880-125C8	12.19	0.65	0.44	0.00	0.00	0.00	0.22	0.00	0.00
CD14+ monocytes - treated with Candida, donor1	11868-125B5	10.30	0.94	0.94	0.00	0.23	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Candida, donor2	11878-125C6	7.39	0.00	0.53	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Candida, donor3	11888-125D7	9.98	1.11	0.00	0.00	1.11	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	14.43	3.27	0.89	0.00	0.30	0.00	0.15	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	13.37	3.39	1.80	0.20	0.40	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	13.74	2.08	1.46	0.21	0.21	0.42	0.00	0.00	0.00
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	12.13	1.83	0.00	0.23	0.23	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	11.31	2.49	1.13	0.00	0.00	0.23	0.00	0.00	0.00
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	9.17	0.00	0.44	0.00	0.44	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	15.60	1.34	2.15	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	14.48	3.49	1.40	0.00	0.17	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	10.52	0.42	1.68	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	9.37	1.84	0.37	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	6.34	1.76	0.35	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	8.77	1.75	0.44	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	12.55	2.27	0.52	0.00	0.17	0.00	0.17	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	10.78	1.49	0.37	0.37	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	17.03	1.94	1.29	0.00	0.22	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	9.01	0.82	0.82	0.00	0.00	0.00	0.00	0.41	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	7.42	0.70	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	6.03	1.39	0.23	0.00	0.46	0.00	0.00	0.00	0.00
CD14+CD16+ Monocytes, donor1	11789-124B7	20.71	3.49	0.22	0.00	0.00	0.00	0.22	0.00	0.00
CD14+CD16+ Monocytes, donor2	11801-124D1	27.03	2.54	1.85	0.23	0.23	0.00	0.23	0.00	0.00
CD14+CD16+ Monocytes, donor3	11912-125G4	23.18	1.73	0.43	0.00	0.22	0.00	0.00	0.22	0.00
CD14+CD16- Monocytes, donor1	11788-124B6	30.52	3.11	2.02	0.16	0.16	0.00	0.00	0.00	0.00
CD14+CD16- Monocytes, donor2	11799-124C8	25.85	1.57	1.40	0.00	0.17	0.17	0.00	0.00	0.00
CD14+CD16- Monocytes, donor3	11910-125G2	21.41	2.01	1.56	0.00	0.45	0.00	0.00	0.00	0.45
CD14-CD16+ Monocytes, donor1	11790-124B8	18.88	6.12	1.28	0.00	0.26	0.00	0.00	0.00	0.00
CD14-CD16+ Monocytes, donor2	11800-124C9	23.05	5.05	0.66	0.00	0.22	0.00	0.00	0.22	0.00
CD14-CD16+ Monocytes, donor3	11911-125G3	24.21	3.58	0.42	0.00	0.21	0.21	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	8.13	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	9.49	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	12.43	1.04	1.04	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	11.73	0.53	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	12.87	0.00	0.54	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	18.95	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	14.90	0.78	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	13.18	0.00	1.32	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells, donor1	11544-120B5	13.15	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells, donor2	11624-122B4	7.98	0.73	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells, donor3	11705-123B4	3.53	0.50	0.50	0.00	0.00	0.00	0.00	0.00	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	9.70	34.75	2.02	0.00	0.00	0.00	0.00	0.00	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	2.80	39.15	2.00	0.00	0.00	0.00	0.00	0.00	0.00
CD34+ Progenitors, donor1	11545-120B6	6.02	2.01	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD34+ Progenitors, donor2	11625-122B5	4.49	1.12	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	17.66	3.38	1.88	0.00	0.00	0.00	0.00	0.00	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	22.55	1.58	1.80	0.00	0.23	0.00	0.00	0.00	0.00
CD4+ T Cells, donor1	11225-116C1	5.71	3.57	0.36	0.00	0.00	0.00	0.00	0.00	0.00
CD4+ T Cells, donor2	11306-117C1	6.12	5.51	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+ T Cells, donor3	11382-118B5	10.98	8.23	0.91	0.30	0.00	0.00	0.00	0.00	0.30
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	20.42	4.59	0.77	0.00	0.00	0.00	0.26	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	19.32	8.31	0.67	0.00	0.00	0.00	0.22	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	22.71	5.75	0.57	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	9.01	1.90	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	8.43	3.51	0.70	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	19.78	3.30	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	16.33	6.21	0.43	0.00	0.14	0.00	0.00	0.00	0.14
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	14.40	7.80	1.19	0.00	0.17	0.00	0.17	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	15.96	5.48	0.64	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	13.45	5.38	0.00	0.00	0.45	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	9.78	4.19	0.35	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	14.96	3.08	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	13.49	3.79	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	20.36	3.95	1.45	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	19.38	9.02	0.00	0.00	0.00	0.00	0.00	0.33	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	8.43	6.80	0.54	0.00	0.00	0.27	0.54	0.00	0.27
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	11.79	6.43	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	10.76	7.17	1.79	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	26.15	8.72	0.74	0.00	0.00	0.19	0.00	0.00	0.19
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	17.55	6.72	1.30	0.22	0.00	0.00	0.00	0.00	0.22
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	18.49	9.25	0.84	0.21	0.00	0.21	0.00	0.21	0.21
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	6.57	11.63	0.51	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	8.67	6.50	0.87	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	9.15	10.90	1.31	0.00	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	18.81	10.39	0.00	0.00	0.00	0.00	0.00	0.00	0.49
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	7.39	10.16	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	9.77	11.17	1.40	0.00	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	17.72	9.42	0.28	0.00	0.28	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	14.97	6.38	0.98	0.00	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	16.94	15.40	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	20.05	6.80	0.00	0.00	0.36	0.00	0.00	0.00	0.36
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	9.69	5.54	2.77	0.00	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells, donor1	11226-116C2	8.84	4.58	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells, donor2	11307-117C2	8.26	5.63	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells, donor3	11383-118B6	9.09	5.55	0.25	0.00	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	16.06	4.59	3.21	0.00	0.23	0.00	0.23	0.00	0.46
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	17.01	4.07	3.12	0.00	0.24	0.00	0.24	0.00	0.24
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	22.71	2.74	2.19	0.27	0.00	0.00	0.00	0.00	0.55
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	15.91	1.80	2.40	0.30	0.00	0.00	0.00	0.30	0.30
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	18.48	3.84	2.40	0.24	0.24	0.00	0.00	0.00	0.72
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	20.24	2.73	2.73	0.00	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	19.12	7.17	3.91	0.00	0.43	0.00	0.22	0.00	0.65
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	19.74	5.00	5.26	0.53	0.00	0.00	0.26	0.00	0.00
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	17.82	5.16	3.99	0.23	0.23	0.00	0.23	0.00	0.00
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	16.60	3.92	2.11	0.60	0.00	0.00	0.00	0.00	1.81
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	17.14	1.45	2.61	0.87	0.00	0.29	0.00	0.00	0.00
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	14.92	4.00	2.40	0.00	0.27	0.00	0.27	0.00	0.27
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	9.63	3.94	3.50	0.00	0.44	0.00	0.00	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	10.93	4.10	2.73	0.00	0.46	0.00	0.00	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	5.22	2.24	2.24	0.00	0.00	0.00	0.00	0.00	0.75
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	15.13	3.24	2.52	0.36	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	15.25	2.01	3.74	0.29	0.00	0.29	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	17.21	3.54	3.54	0.00	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	19.65	5.39	2.85	0.00	0.32	0.00	0.00	0.00	0.32
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	15.69	4.92	4.61	0.00	0.00	0.00	0.00	0.00	0.31
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	13.14	4.81	2.89	0.00	0.00	0.00	0.00	0.00	0.96
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	9.56	4.21	2.29	0.38	0.00	0.00	0.00	0.00	0.38
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	13.79	6.31	1.18	0.39	0.39	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	18.91	2.27	2.27	0.76	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	12.04	4.01	1.61	0.80	0.00	0.00	0.00	0.00	1.61
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	16.79	2.80	1.40	0.00	0.00	0.00	0.00	0.00	0.70
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	15.03	5.01	1.00	0.00	0.00	0.00	0.00	0.00	1.00
Cardiac Myocyte, donor1	11525-119I4	49.35	5.48	1.83	0.00	0.00	0.00	0.00	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	33.10	26.19	10.38	0.49	0.49	0.00	0.00	0.00	0.49
Cardiac Myocyte, donor3	11686-122I3	39.25	22.20	9.89	0.63	0.32	0.00	0.21	0.00	0.00
Chondrocyte - de diff, donor1	11261-116G1	47.49	23.23	10.75	0.35	1.04	0.00	0.00	0.00	0.69
Chondrocyte - de diff, donor2	11338-117F6	47.98	16.35	7.82	0.36	0.36	0.00	0.00	0.00	0.36
Chondrocyte - de diff, donor3	11410-118E6	45.28	10.47	4.21	0.11	0.57	0.46	0.46	0.23	0.34
Chondrocyte - re diff, donor2	11339-117F7	21.49	25.96	5.37	0.90	0.00	0.00	0.00	0.00	0.90
Chondrocyte - re diff, donor3	11411-118E7	40.84	47.72	10.51	0.40	0.40	0.00	0.00	0.00	0.40
Ciliary Epithelial Cells, donor1	11242-116D9	24.21	2.52	4.59	0.11	0.23	0.00	0.00	0.00	0.00
Ciliary Epithelial Cells, donor2	11323-117D9	32.49	3.85	4.92	0.21	0.21	0.00	0.00	0.00	0.21
Ciliary Epithelial Cells, donor3	11399-118D4	31.06	5.13	5.04	0.18	0.18	0.00	0.00	0.00	0.35
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	22.65	7.06	2.75	0.37	0.09	0.09	0.00	0.00	0.37
Corneal Epithelial Cells, donor1	11526-119I5	28.54	8.12	3.51	0.22	0.00	0.00	0.00	0.00	0.00
Corneal Epithelial Cells, donor2	11606-120I4	14.79	1.14	1.14	0.00	0.00	0.00	0.00	0.00	0.00
Corneal Epithelial Cells, donor3	11687-122I4	16.10	6.14	2.81	0.00	0.00	0.00	0.00	0.00	0.26
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	19.48	22.12	11.23	0.83	0.83	0.00	0.17	0.00	0.99
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	19.56	21.13	10.41	0.00	0.32	0.00	0.00	0.00	0.95
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	13.80	13.80	3.45	3.45	0.00	0.00	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	18.14	10.37	8.42	1.08	0.43	0.11	0.11	0.11	0.11
Dendritic Cells - plasmacytoid, donor1	11228-116C4	10.93	5.47	1.71	0.34	0.00	0.00	0.00	0.00	0.34
Dendritic Cells - plasmacytoid, donor2	11309-117C4	11.10	1.31	3.26	0.00	0.00	0.00	0.00	0.00	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	7.74	3.87	0.48	0.00	0.00	0.00	0.00	0.00	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	36.86	13.34	7.50	0.00	1.17	0.00	0.00	0.00	0.83
Endothelial Cells - Aortic, donor1	11263-116G3	34.03	15.84	8.80	1.17	0.00	0.00	0.00	0.00	0.59
Endothelial Cells - Aortic, donor2	11340-117F8	46.10	18.10	8.48	0.57	1.41	0.00	0.00	0.00	0.00
Endothelial Cells - Aortic, donor3	11412-118E8	42.46	27.52	5.90	0.79	0.79	0.00	0.00	0.00	1.57
Endothelial Cells - Artery, donor1	11264-116G4	51.48	17.16	6.69	0.29	1.45	0.00	0.29	0.00	0.00
Endothelial Cells - Artery, donor2	11341-117F9	68.23	9.18	10.12	0.00	1.41	0.47	0.71	0.24	0.00
Endothelial Cells - Artery, donor3	11413-118E9	42.42	14.73	7.71	0.88	1.93	0.18	0.18	0.00	1.23
Endothelial Cells - Lymphatic, donor1	11236-116D3	40.56	14.63	4.21	0.22	2.66	0.00	0.22	0.00	0.22
Endothelial Cells - Lymphatic, donor2	11317-117D3	31.34	12.78	4.87	0.30	1.22	0.00	0.61	0.00	0.30
Endothelial Cells - Lymphatic, donor3	11393-118C7	47.64	15.79	2.54	0.28	0.85	0.00	0.28	0.28	0.00
Endothelial Cells - Microvascular, donor1	11265-116G5	34.47	12.18	8.02	0.30	0.59	0.30	0.30	0.00	0.00
Endothelial Cells - Microvascular, donor2	11342-117G1	22.91	7.29	5.21	0.00	0.00	0.00	0.00	0.00	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	28.78	7.80	5.81	0.28	0.57	0.00	0.28	0.28	0.43
Endothelial Cells - Thoracic, donor1	11266-116G6	48.01	16.40	9.20	0.40	0.80	0.40	0.40	0.00	0.80
Endothelial Cells - Thoracic, donor2	11343-117G2	69.71	11.53	5.77	1.05	1.57	0.00	0.00	0.00	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	55.41	11.55	5.59	0.37	1.37	0.12	0.12	0.00	0.50
Endothelial Cells - Umbilical vein, donor2	11324-117E1	31.07	9.99	4.35	0.22	0.22	0.00	0.22	0.00	0.22
Endothelial Cells - Umbilical vein, donor3	11400-118D5	29.80	9.40	5.13	0.61	1.22	0.00	0.00	0.00	0.12
Endothelial Cells - Vein, donor1	11267-116G7	38.68	14.79	11.38	0.00	1.14	0.00	0.00	0.00	1.14
Endothelial Cells - Vein, donor2	11344-117G3	53.09	13.97	7.68	0.00	0.70	0.00	0.00	0.00	1.40
Endothelial Cells - Vein, donor3	11416-118F3	35.95	11.62	6.91	0.16	1.88	0.00	0.00	0.00	0.00
Eosinophils, donor1	12244-129H3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	3.30	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor3	12246-129H5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	23.21	9.28	3.91	0.00	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor2	11587-120G3	10.40	4.16	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	65.08	16.27	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	50.08	29.97	8.21	2.05	0.00	0.00	0.00	0.00	0.82
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	34.38	20.15	6.13	0.55	0.77	0.44	0.44	0.66	0.99
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	12.13	3.68	0.65	0.00	0.00	0.00	0.00	0.22	0.22
Fibroblast - Aortic Adventitial, donor1	11245-116E3	49.72	18.92	8.97	0.61	0.49	0.36	0.61	0.24	0.49
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	86.93	37.26	13.78	1.23	2.05	0.00	0.27	0.14	1.09
Fibroblast - Aortic Adventitial, donor2	11326-117E3	52.00	27.84	10.76	0.74	0.53	0.11	0.42	0.21	0.32
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	165.74	71.41	37.15	1.32	2.37	0.53	1.32	0.79	0.53
Fibroblast - Aortic Adventitial, donor3	11401-118D6	43.85	26.24	12.29	0.66	0.33	0.00	0.33	0.00	0.00
Fibroblast - Cardiac, donor1	11268-116G8	36.29	11.34	4.54	0.00	0.00	0.00	0.00	0.45	0.00
Fibroblast - Cardiac, donor2	11345-117G4	49.27	14.40	8.34	0.76	0.76	0.00	0.00	0.00	0.00
Fibroblast - Cardiac, donor3	11417-118F4	66.40	18.30	11.04	0.16	0.63	0.16	0.32	0.16	1.42
Fibroblast - Cardiac, donor4	11452-119A3	30.31	15.76	6.06	0.00	0.00	0.30	0.30	0.30	0.00
Fibroblast - Cardiac, donor5	11456-119A7	32.61	18.53	10.28	0.13	0.51	0.51	0.13	0.13	0.76
Fibroblast - Cardiac, donor6	11460-119B2	29.11	20.16	9.70	1.21	1.21	0.00	0.15	0.00	1.21
Fibroblast - Choroid Plexus, donor1	11492-119E7	37.92	8.31	7.77	0.13	0.40	0.00	0.13	0.00	0.00
Fibroblast - Choroid Plexus, donor2	11572-120E6	31.49	5.61	3.88	0.00	0.43	0.00	0.00	0.00	0.00
Fibroblast - Choroid Plexus, donor3	11653-122E6	41.01	17.58	11.72	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	70.34	37.13	19.60	0.69	1.85	0.23	0.00	0.23	0.92
Fibroblast - Conjunctival, donor3	11692-122I9	37.48	20.86	6.28	0.17	0.17	0.00	0.00	0.17	0.17
Fibroblast - Dermal, donor1	11269-116G9	25.59	10.10	6.10	0.23	0.00	0.23	0.47	0.00	0.94
Fibroblast - Dermal, donor2	11346-117G5	29.72	16.51	9.43	0.47	0.94	0.00	0.00	0.00	0.00
Fibroblast - Dermal, donor3	11418-118F5	24.18	28.53	9.43	0.60	0.36	0.00	0.48	0.00	0.48
Fibroblast - Dermal, donor4	11450-119A1	31.99	16.39	10.17	1.13	0.45	0.00	0.11	0.11	0.79
Fibroblast - Dermal, donor5	11454-119A5	32.27	15.35	9.94	0.52	0.52	0.00	0.17	0.00	0.70
Fibroblast - Dermal, donor6	11458-119A9	36.38	19.00	10.56	0.00	0.65	0.00	0.00	0.00	0.65
Fibroblast - Gingival, donor1	11237-116D4	18.12	17.28	5.83	0.83	0.42	0.21	0.00	0.00	0.21
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	39.82	31.70	12.84	0.26	0.26	0.00	0.26	0.26	1.05
Fibroblast - Gingival, donor2	11318-117D4	18.71	22.67	10.15	0.79	0.26	0.00	0.26	0.00	0.40
Fibroblast - Gingival, donor3	11394-118C8	18.66	22.04	8.51	0.29	0.19	0.00	0.19	0.00	0.48
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	42.59	23.89	11.43	0.00	0.00	0.00	1.04	0.00	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	64.49	22.55	10.75	0.35	0.18	0.00	0.18	0.53	0.35
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	25.41	25.57	11.54	1.40	0.31	0.16	0.16	0.00	1.25
Fibroblast - Gingival, donor6 (control)	11922-125H5	19.74	26.37	14.06	0.00	0.27	0.00	0.14	0.14	0.68
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	105.51	36.70	19.76	0.71	1.06	0.00	0.00	0.00	0.71
Fibroblast - Gingival, donor7 (control)	11924-125H7	32.76	17.70	10.09	0.44	0.44	0.00	0.29	0.00	0.73
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	36.54	20.04	10.50	0.14	0.27	0.14	0.00	0.00	0.14
Fibroblast - Gingival, donor8 (control)	11926-125H9	45.85	24.79	14.37	0.99	0.55	0.33	0.11	0.22	0.55
Fibroblast - Gingival, donor9 (control)	11927-125I1	45.78	28.32	12.33	0.59	0.59	0.15	0.15	0.15	0.15
Fibroblast - Lung, donor1	11270-116H1	19.03	29.91	13.59	1.36	0.00	0.00	0.00	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	17.91	22.38	11.94	2.98	1.49	0.00	0.00	0.00	1.49
Fibroblast - Lung, donor3	11419-118F6	22.37	54.45	16.25	1.06	0.21	0.21	1.06	0.21	0.63
Fibroblast - Lymphatic, donor1	11506-119G3	53.31	47.48	30.82	0.83	0.00	0.00	0.00	0.00	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	20.98	11.19	9.79	1.40	1.40	0.00	0.00	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	46.74	37.50	17.07	1.12	0.56	0.00	0.56	0.00	1.12
Fibroblast - Mammary, donor1	11540-120B1	47.09	25.58	12.99	1.22	1.22	0.00	0.00	0.00	0.81
Fibroblast - Mammary, donor2	11620-122A9	63.91	19.97	7.99	3.99	0.00	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	47.65	29.78	0.00	0.00	11.91	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	22.11	18.04	8.92	0.58	0.19	0.00	0.39	0.19	0.39
Fibroblast - Periodontal Ligament, donor2	11319-117D5	31.55	14.41	9.25	0.76	0.76	0.00	0.46	0.15	0.61
Fibroblast - Periodontal Ligament, donor3	11395-118C9	16.52	15.91	7.34	1.22	0.00	0.00	0.00	0.00	0.31
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	32.44	14.50	11.07	0.76	0.38	0.00	0.00	0.00	0.76
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	43.20	19.98	7.56	0.00	0.81	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	60.31	22.61	8.35	1.04	0.58	0.00	0.12	0.35	0.35
Fibroblast - Pulmonary Artery, donor1	11250-116E8	54.27	23.99	10.17	0.99	1.22	0.22	0.11	0.00	0.55
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	43.48	49.58	23.37	2.03	0.41	0.20	0.00	0.00	0.41
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	38.76	20.05	12.03	0.67	0.67	0.00	0.00	0.00	0.67
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	25.30	17.79	8.70	0.79	0.00	0.00	0.40	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	116.69	45.64	22.03	1.19	2.98	0.20	0.40	0.00	2.18
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	56.66	21.67	11.55	0.71	0.71	0.18	0.00	0.18	0.36
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	53.02	16.16	8.87	0.59	0.20	0.39	0.20	0.00	0.39
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	152.83	61.68	43.62	3.91	1.50	0.00	0.60	0.00	1.50
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	46.31	25.69	10.36	0.76	0.22	0.11	0.22	0.00	1.19
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	104.01	46.31	20.50	2.02	1.01	0.51	0.00	0.00	1.01
Fibroblast - skin normal, donor1	11553-120C5	53.98	28.39	13.78	0.49	0.33	0.00	0.82	0.00	0.49
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	152.79	67.97	33.08	2.41	2.41	0.00	1.20	0.20	2.81
Fibroblast - skin normal, donor2	11561-120D4	51.84	36.07	10.75	0.70	1.21	0.10	0.00	0.10	0.50
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	91.88	44.73	25.99	2.42	0.60	0.00	0.30	0.00	3.02
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	48.38	23.45	7.29	0.58	0.66	0.08	0.17	0.00	0.58
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	31.11	11.62	3.25	0.00	0.68	0.17	0.00	0.00	0.00
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	168.16	56.49	25.95	0.99	1.31	0.00	0.33	0.66	1.64
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	52.30	20.03	12.14	0.64	1.07	0.11	0.32	0.00	0.53
Fibroblast - skin walker warburg, donor1	11554-120C6	47.06	23.95	8.60	0.67	0.51	0.17	0.00	0.00	0.51
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	51.75	19.76	6.90	0.78	0.47	0.94	0.47	0.16	0.31
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	0.00	22.16	22.16	22.16	0.00	0.00	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	6.10	3.49	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	28.08	22.02	3.29	0.52	0.35	0.17	0.17	0.00	0.00
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	20.82	18.22	4.94	0.00	0.52	0.00	0.00	0.00	0.26
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	20.95	12.78	2.81	0.00	0.51	0.00	0.00	0.26	0.26
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	13.78	3.06	10.72	0.00	0.00	0.00	0.00	0.00	0.77
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	26.16	1.91	8.29	0.64	0.00	0.00	0.00	0.00	0.64
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	31.09	1.14	8.27	0.00	0.00	0.00	0.29	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	16.55	4.41	25.09	0.55	0.00	0.00	0.55	0.55	0.28
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	21.01	2.74	13.93	0.00	0.00	0.46	0.68	0.46	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	31.90	1.78	9.51	0.20	0.00	0.20	0.00	0.20	0.40
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	14.54	2.11	24.85	0.53	0.26	0.26	1.32	0.26	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	14.68	6.52	11.74	0.33	0.00	0.00	0.33	0.65	0.33
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	30.96	0.88	3.10	0.44	0.44	0.44	0.00	0.00	0.44
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	24.31	2.54	6.08	0.14	0.28	0.14	0.28	0.14	0.14
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	23.89	5.05	6.28	0.74	0.86	0.12	0.12	0.00	0.25
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	21.22	2.95	4.30	0.00	0.27	0.00	0.00	0.27	0.00
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	36.80	9.17	9.42	0.62	0.25	0.00	0.25	0.25	1.12
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	33.91	6.64	7.89	0.42	0.55	0.00	0.14	0.00	0.42
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	30.90	4.27	6.30	1.22	0.00	0.00	0.00	0.00	0.41
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	30.35	15.06	10.72	0.91	0.00	0.46	0.23	0.23	0.91
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	38.37	11.09	11.34	0.50	0.00	0.00	0.00	0.12	0.62
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	36.72	6.99	9.18	0.66	0.22	0.22	0.00	0.00	0.22
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	35.46	19.21	5.32	0.59	0.00	0.30	1.48	0.00	1.18
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	29.41	11.29	7.47	0.32	0.00	0.16	0.00	0.00	0.64
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	30.61	5.59	7.82	0.22	0.45	0.00	0.00	0.00	0.45
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	32.06	32.46	7.86	1.81	0.20	0.20	0.60	0.20	1.21
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	35.12	22.22	7.97	0.34	0.34	0.34	0.00	0.00	0.68
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	42.92	22.61	11.26	1.33	0.71	0.27	0.44	0.09	0.80
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	45.37	56.19	12.28	1.98	0.21	0.21	0.52	0.31	1.46
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	44.23	46.96	10.93	1.37	0.34	0.17	1.54	0.17	1.02
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	32.53	31.76	7.75	1.11	0.33	0.33	0.44	0.11	0.89
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	37.36	32.28	11.31	1.16	1.00	0.00	0.33	0.42	0.83
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	33.69	25.52	13.88	1.63	0.20	0.20	0.61	0.41	1.43
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	31.98	38.99	11.97	1.24	0.41	0.41	0.83	0.41	1.44
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	34.59	24.10	8.42	0.35	0.46	0.58	0.35	0.12	0.58
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	36.19	42.19	10.84	1.50	0.17	0.17	0.33	0.17	1.17
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	35.49	48.05	9.92	1.32	0.22	0.22	0.88	0.22	0.88
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	39.85	52.76	10.58	1.11	0.49	0.61	0.61	0.49	0.98
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	28.04	31.61	8.10	0.32	0.32	0.49	0.65	0.16	0.97
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	32.39	41.37	8.98	0.32	0.64	0.00	0.64	0.32	0.64
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	37.81	42.54	10.33	1.52	0.57	0.47	0.47	0.28	1.23
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	35.91	51.57	10.91	1.11	0.63	0.47	0.79	0.47	0.63
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	41.66	56.86	12.47	1.52	0.00	0.30	0.30	0.00	1.52
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	41.29	50.28	10.45	1.46	0.84	0.42	0.42	0.31	1.36
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	27.66	49.62	9.44	1.32	0.66	0.44	0.22	0.44	1.10
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	37.59	51.90	6.73	0.00	0.28	0.00	1.12	0.28	0.56
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	38.79	60.00	12.04	2.22	0.28	0.28	0.09	0.00	1.85
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	39.84	60.17	14.44	1.60	0.27	0.53	0.53	0.27	1.07
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	43.61	77.27	13.62	1.84	0.46	0.00	0.46	0.15	1.84
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	41.58	55.05	7.90	0.65	0.26	0.26	0.65	0.13	2.33
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	26.57	52.86	6.78	2.71	0.54	0.27	0.54	0.27	1.90
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	41.29	49.96	9.95	2.21	0.55	0.00	0.74	0.00	2.03
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	46.27	48.25	8.77	1.10	0.22	0.22	0.66	0.22	1.10
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	26.78	40.66	8.93	0.99	0.00	0.00	0.00	0.00	0.99
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	44.59	34.03	8.05	1.19	0.26	0.13	0.13	0.13	1.19
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	39.54	31.47	8.88	0.81	0.61	0.61	0.40	0.20	1.21
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	27.70	31.01	8.13	0.25	0.00	0.00	0.00	0.00	1.27
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	27.27	3.18	5.77	0.40	0.00	0.00	0.20	0.00	0.40
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	25.58	2.62	3.70	0.77	0.31	0.31	0.00	0.00	0.31
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	30.28	1.43	5.32	0.00	0.20	0.00	0.00	0.00	0.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	11.89	1.56	9.07	0.63	0.31	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	9.04	0.28	4.52	0.00	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	10.61	0.46	3.23	0.46	0.00	0.00	0.00	0.00	0.46
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	9.90	0.00	7.42	0.00	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	9.67	0.39	5.42	0.39	0.00	0.39	0.39	0.77	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	16.04	3.21	4.81	0.00	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	12.17	1.74	3.48	0.00	0.00	0.00	0.00	0.00	1.74
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	9.11	1.30	5.21	0.65	0.00	0.00	0.00	0.33	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	11.12	1.24	4.94	0.00	0.41	0.41	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	16.66	0.00	3.33	0.00	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	7.83	1.40	5.31	0.28	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	9.15	1.31	3.27	0.00	0.00	0.00	0.00	0.00	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	12.58	0.00	4.19	0.00	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	11.13	1.27	7.63	0.32	0.32	0.32	0.64	0.32	0.95
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	9.85	0.68	3.40	0.34	0.00	0.34	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	10.44	4.18	2.09	0.00	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	13.74	3.44	8.59	0.00	0.00	0.57	1.15	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	10.36	1.78	4.14	0.00	0.00	0.00	0.30	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	6.78	0.00	5.08	0.00	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	12.01	2.90	6.21	0.41	0.00	0.00	0.00	0.00	0.83
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	8.98	3.45	5.98	0.23	0.00	0.00	0.23	0.23	0.46
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	21.07	10.54	0.00	0.00	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	9.99	1.92	3.84	0.38	0.77	0.00	0.38	0.00	0.38
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	12.71	0.98	5.54	0.00	0.00	0.00	0.65	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	8.69	3.34	5.35	0.67	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	18.49	1.54	5.39	0.00	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	14.38	4.45	6.50	0.00	0.00	0.00	0.34	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	9.94	2.48	12.42	2.48	0.00	0.00	2.48	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	14.16	5.19	7.55	0.47	0.47	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	14.48	2.41	3.02	0.60	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	19.84	5.09	6.61	0.00	0.00	0.51	0.00	1.02	0.51
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	15.16	2.39	5.58	0.80	0.00	0.00	0.40	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	18.25	0.49	5.92	0.00	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	16.53	4.72	10.62	0.00	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	21.59	0.58	5.25	0.00	0.00	1.17	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	17.56	2.63	9.22	0.44	0.00	0.00	0.44	0.88	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	14.41	2.54	5.09	0.00	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	16.71	1.19	7.16	0.60	0.00	0.00	0.00	0.60	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	15.04	4.37	4.85	0.49	0.00	0.00	0.49	0.49	0.97
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	37.66	18.26	11.41	0.00	0.00	0.00	0.00	0.00	1.14
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	50.31	27.03	4.99	0.42	0.42	0.42	1.25	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	41.60	34.86	16.87	0.00	1.12	0.00	0.00	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	27.28	4.76	3.17	0.00	0.00	0.32	0.00	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	20.89	10.03	1.67	0.42	0.42	0.42	0.00	0.00	0.00
Hep-2 cells mock treated, biol_rep1	11898-125E8	26.81	8.59	4.06	0.00	0.35	0.12	0.12	0.23	0.23
Hep-2 cells mock treated, biol_rep2	11899-125E9	28.53	7.09	4.05	0.68	0.34	0.00	0.00	0.00	0.17
Hep-2 cells mock treated, biol_rep3	11900-125F1	27.53	5.01	4.10	0.23	0.23	0.00	0.00	0.00	0.23
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	29.08	7.76	6.12	0.33	0.33	0.22	0.11	0.00	0.33
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	30.73	9.46	5.80	0.64	0.43	0.00	0.00	0.00	0.21
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	33.80	4.52	6.24	0.22	0.43	0.00	0.00	0.00	0.43
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	23.79	7.60	5.98	0.00	0.25	0.12	0.12	0.37	0.12
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	22.64	6.35	5.15	0.17	0.51	0.00	0.17	0.34	0.17
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	21.79	4.16	5.13	0.00	0.00	0.00	0.00	0.00	0.32
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	34.70	18.47	11.19	0.56	0.00	0.00	0.56	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	66.22	25.97	16.88	0.87	2.16	0.00	0.00	0.00	0.43
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	42.30	13.22	10.58	0.00	0.00	0.00	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	38.45	23.63	12.35	1.41	0.71	0.00	0.00	0.00	0.71
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	42.86	22.52	9.44	0.73	0.73	0.00	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	24.48	25.18	8.74	1.22	0.52	0.35	0.00	0.17	0.87
Hepatocyte, donor1	11523-119I2	31.48	0.00	6.05	1.21	0.00	0.00	0.00	0.00	0.00
Hepatocyte, donor2	11603-120I1	58.18	2.15	2.15	0.00	1.08	0.00	0.00	0.00	0.00
Hepatocyte, donor3	11684-122I1	46.02	2.45	4.29	1.23	1.23	0.00	0.00	0.61	0.61
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	3.92	0.65	0.65	0.00	0.00	0.00	0.00	0.00	0.00
Intestinal epithelial cells (polarized), donor1	11246-116E4	22.90	13.11	8.56	0.70	0.17	0.00	0.00	0.00	0.00
Iris Pigment Epithelial Cells, donor1	11530-119I9	44.32	10.15	7.13	0.41	0.41	0.14	0.14	0.14	0.14
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	76.41	15.92	28.66	3.18	3.18	3.18	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	6.68	20.03	26.70	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	81.25	27.08	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	63.68	26.30	16.61	2.77	0.00	0.00	0.00	1.38	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	42.55	10.01	10.01	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	106.81	35.60	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	94.83	12.81	25.63	2.56	2.56	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	41.14	18.28	18.28	0.00	0.00	0.00	0.00	0.00	9.14
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	79.59	19.49	29.24	0.00	3.25	1.62	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	45.02	5.00	20.01	0.00	1.67	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	32.68	7.26	14.52	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	88.67	22.50	21.18	0.00	0.00	0.00	0.00	0.00	1.32
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	54.32	12.20	13.30	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	62.86	20.95	20.95	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	48.50	13.86	14.49	0.63	1.26	0.00	1.26	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	43.31	24.75	13.92	1.55	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	58.54	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	62.02	22.61	23.26	0.65	0.00	0.00	0.00	0.00	1.29
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	77.28	22.54	22.54	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	35.84	0.00	11.95	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	55.41	17.93	17.11	1.63	0.81	0.81	0.00	0.81	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	63.81	26.03	20.15	0.42	0.00	0.00	0.00	0.00	0.84
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	43.12	14.37	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	57.87	17.68	20.09	0.00	0.80	0.00	0.00	0.00	0.80
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	29.55	8.31	22.16	0.00	0.92	0.00	0.00	0.00	0.92
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	30.16	15.08	15.08	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	42.48	14.63	9.44	0.47	0.00	0.00	0.00	0.00	0.47
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	46.26	17.23	16.33	0.00	0.00	0.00	0.00	0.00	0.91
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	29.48	14.74	29.48	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	69.95	22.60	19.37	0.00	0.00	0.00	0.00	0.00	1.08
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	66.06	25.41	27.95	0.00	2.54	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	0.00	32.86	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	70.78	29.97	20.41	0.64	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	71.08	23.69	25.52	0.00	0.00	0.00	0.00	0.00	1.82
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	15.80	47.41	15.80	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	87.12	17.85	17.14	0.00	0.00	0.00	0.71	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	119.46	19.91	29.86	0.00	0.00	0.00	0.00	3.32	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	62.55	20.85	62.55	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	62.35	15.12	20.68	0.31	0.93	0.00	0.00	0.00	0.31
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	84.29	28.10	26.34	1.76	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	69.15	12.57	15.72	3.14	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	88.31	22.95	28.51	0.00	1.39	0.00	0.00	0.00	0.70
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	64.18	13.28	17.70	2.21	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	32.42	6.48	12.97	3.24	0.00	0.00	0.00	0.00	3.24
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	55.80	22.67	8.72	0.00	0.00	0.00	0.87	0.00	0.87
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	31.50	15.75	20.25	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	45.30	31.36	24.39	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	48.00	8.53	19.20	0.00	0.00	0.00	0.00	1.07	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	56.80	22.17	18.01	1.39	1.39	0.00	0.00	0.00	1.39
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	91.19	42.74	34.20	0.00	8.55	0.00	0.00	0.00	2.85
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	61.67	16.57	23.93	0.00	0.92	0.00	0.00	0.92	0.92
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	39.33	9.08	9.08	0.00	0.00	0.00	3.03	3.03	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	24.83	24.83	18.63	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	53.93	12.69	23.26	0.00	2.11	1.06	0.00	0.00	0.00
Keratinocyte - epidermal, donor1	11272-116H3	32.48	15.01	1.71	0.16	0.08	0.00	0.16	0.16	0.33
Keratinocyte - epidermal, donor2	11349-117G8	22.84	4.69	4.69	0.00	0.00	0.00	0.00	0.00	0.59
Keratinocyte - epidermal, donor3	11421-118F8	20.16	7.48	1.80	0.09	0.00	0.09	0.00	0.00	0.00
Keratinocyte - oral, donor1	11251-116E9	38.94	6.58	4.20	0.00	0.34	0.00	0.00	0.00	0.11
Keratocytes, donor1	11527-119I6	56.39	42.98	30.60	1.72	0.34	0.00	0.00	0.34	1.03
Keratocytes, donor2	11607-120I5	46.87	33.98	18.75	0.00	2.34	0.00	0.00	0.00	0.00
Keratocytes, donor3	11688-122I5	29.24	32.80	14.23	0.59	0.40	0.00	0.20	0.00	0.20
Krukenberg tumor cell line:HSKTC	10687-109F3	28.57	39.56	13.19	0.00	0.00	0.00	0.00	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	36.68	5.39	4.31	0.00	0.00	0.00	0.00	2.16	0.00
Lens Epithelial Cells, donor2	11609-120I7	32.29	3.23	5.07	0.23	0.00	0.00	0.12	0.00	0.12
Lens Epithelial Cells, donor3	11690-122I7	42.89	14.53	4.94	0.30	0.50	0.00	0.10	0.00	0.40
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	35.10	8.66	6.05	0.47	0.95	0.12	0.36	0.24	0.12
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	22.88	6.42	4.74	0.28	0.84	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	27.70	7.24	5.35	0.16	0.94	0.16	0.16	0.31	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	19.90	6.45	4.84	0.54	1.08	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	26.16	5.99	6.30	0.32	1.26	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	30.62	5.50	3.34	0.32	0.43	0.11	0.00	0.00	0.32
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	27.91	5.75	6.57	0.00	0.00	0.00	0.00	0.41	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	21.49	7.08	4.80	0.25	0.00	0.00	0.25	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	27.73	6.90	3.10	0.28	0.14	0.14	0.14	0.00	0.14
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	15.43	6.33	4.35	0.40	1.19	0.40	0.79	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	19.39	5.23	5.04	0.58	0.58	0.19	0.00	0.19	0.19
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	30.55	4.07	4.07	0.37	0.74	0.00	0.19	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	23.34	5.57	1.05	0.35	0.35	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	26.48	4.77	7.39	0.48	0.72	0.00	0.00	0.00	0.24
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	26.23	6.18	4.12	0.14	0.55	0.14	0.00	0.27	0.14
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	23.10	4.93	3.08	0.00	0.00	0.00	0.31	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	22.45	7.17	4.36	0.31	0.00	0.31	0.00	0.00	0.31
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	33.85	7.32	4.21	0.18	0.91	0.00	0.00	0.00	0.18
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	18.76	2.96	1.32	0.66	0.33	0.00	0.33	0.33	0.33
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	31.04	7.32	6.15	0.29	0.88	0.00	0.00	0.00	0.29
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	34.10	6.22	5.23	0.00	0.50	0.00	0.25	0.00	0.25
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	23.76	4.36	3.88	0.48	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	20.20	5.12	2.69	0.27	0.27	0.00	0.00	0.27	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	31.79	5.60	6.51	0.00	1.06	0.00	0.30	0.15	0.15
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	17.11	4.67	1.56	0.00	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	19.89	6.49	5.65	0.00	0.42	0.00	0.21	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	29.62	5.71	7.07	0.00	0.45	0.15	0.60	0.15	0.30
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	24.08	5.50	1.38	0.69	1.38	0.00	0.00	0.00	0.69
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	20.51	4.89	5.08	0.56	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	26.19	6.47	4.45	0.00	0.21	0.11	0.21	0.00	0.21
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	23.74	5.81	4.36	0.00	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	15.88	4.63	2.98	0.00	0.00	0.00	0.00	0.00	0.33
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	29.49	6.57	4.21	0.25	0.50	0.00	0.00	0.37	0.25
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	29.62	3.70	3.33	0.00	0.37	0.00	0.00	0.37	0.37
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	14.82	6.92	5.44	0.25	0.25	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	24.89	5.22	4.67	0.00	0.55	0.14	0.00	0.00	0.27
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	24.77	6.11	2.89	0.00	0.96	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	21.00	6.70	5.17	0.00	0.00	0.00	0.30	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	25.47	7.70	3.36	0.00	0.28	0.00	0.42	0.28	0.14
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	24.89	3.56	4.98	0.36	0.00	0.00	0.36	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	15.51	9.21	4.36	0.48	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	28.32	6.22	3.42	0.47	0.47	0.00	0.00	0.00	0.31
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	26.50	6.80	4.30	0.36	0.36	0.00	0.00	0.00	0.36
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	13.72	7.19	2.94	0.00	0.65	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	32.02	7.06	3.53	0.47	0.94	0.00	0.24	0.47	0.47
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	27.97	7.55	4.46	0.50	0.62	0.12	0.37	0.12	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	17.93	6.92	7.17	0.00	0.51	0.00	0.51	0.00	0.26
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	22.68	4.18	3.58	0.00	0.90	0.60	0.00	0.00	0.60
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	31.72	2.27	2.27	2.27	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	25.32	3.84	4.60	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	19.30	8.16	4.45	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	31.73	8.04	7.19	0.00	0.85	0.00	0.00	0.00	0.42
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	30.95	4.92	3.52	0.00	0.00	0.00	0.70	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	22.42	2.80	0.00	0.00	0.93	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	34.52	5.15	4.12	0.00	0.52	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	24.98	5.95	3.57	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	31.44	5.20	4.75	0.00	0.23	0.00	0.23	0.00	0.45
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	31.12	6.11	2.91	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	25.21	4.05	4.50	0.00	0.00	0.00	0.00	0.00	0.45
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	38.34	4.88	4.88	0.27	0.14	0.00	0.27	0.14	0.41
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	41.08	7.19	4.62	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	21.88	3.88	4.94	0.00	0.00	0.00	0.00	0.00	0.71
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	15.99	2.00	2.00	0.67	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	28.02	4.08	3.06	0.00	0.00	0.51	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	26.95	4.80	2.13	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	24.75	4.53	2.83	0.00	0.38	0.00	0.19	0.19	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	28.22	2.45	4.29	0.00	0.61	0.00	0.61	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	28.54	5.71	3.26	0.00	0.00	0.82	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	32.28	4.37	2.92	0.21	0.21	0.21	0.21	0.00	0.21
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	29.99	2.24	3.36	0.28	0.56	0.56	0.28	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	30.91	4.12	2.06	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	30.19	4.06	5.52	0.00	0.29	0.00	0.00	0.29	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	23.62	5.08	5.08	0.00	0.30	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	19.36	6.09	3.32	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	40.30	6.72	5.30	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	32.08	5.90	4.43	0.74	0.37	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	23.03	4.61	8.06	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	36.46	3.84	7.29	0.00	0.00	0.00	0.38	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	38.50	6.23	7.93	0.00	0.00	0.00	0.00	0.00	0.57
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	32.00	3.28	4.92	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	29.37	4.07	5.42	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	31.60	7.18	11.49	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	30.62	2.24	5.98	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	41.62	3.72	7.43	0.37	0.00	0.74	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	28.86	6.89	4.74	0.43	0.00	0.00	0.43	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	20.55	2.57	5.14	0.00	0.00	0.86	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	35.98	5.33	3.00	0.33	0.00	0.67	0.00	0.00	0.33
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	33.79	4.22	3.02	0.00	0.00	0.60	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	27.73	3.55	2.84	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	37.81	4.12	4.12	0.00	0.34	0.00	0.00	0.00	0.34
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	40.79	7.51	5.90	0.54	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	32.32	4.04	6.06	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	35.93	3.70	6.67	0.37	0.00	0.00	0.00	0.00	0.37
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	36.05	2.33	3.49	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	32.79	5.29	3.17	0.00	0.00	0.00	1.06	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	40.02	3.20	4.00	0.00	0.80	0.00	0.40	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	29.07	3.63	5.09	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	27.59	3.83	3.07	0.00	0.00	0.00	0.00	0.00	0.77
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	31.08	1.48	2.47	0.00	0.49	0.49	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	28.23	2.82	4.70	0.00	1.88	0.94	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	29.16	2.01	4.53	0.00	0.50	0.00	0.50	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	31.54	3.60	3.60	0.45	0.00	0.90	0.90	0.00	0.45
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	37.86	1.72	3.44	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	26.28	3.56	4.01	0.45	0.00	0.00	0.00	0.00	0.45
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	28.94	3.52	3.91	0.39	0.39	0.00	0.39	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	22.43	5.28	5.28	0.00	0.00	0.00	0.00	0.00	0.66
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	28.54	2.59	4.15	0.00	0.52	0.00	0.00	0.52	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	42.44	4.81	6.56	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	27.96	4.47	6.71	0.56	0.00	0.00	0.00	0.00	0.56
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	25.62	2.21	5.30	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	37.41	3.09	6.56	0.39	0.00	0.00	0.39	0.00	0.39
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	27.85	9.62	4.05	0.00	0.51	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	36.05	4.33	5.29	0.00	0.48	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	37.37	4.37	5.57	0.80	0.40	0.00	0.00	0.00	0.80
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	34.03	3.65	6.08	1.22	0.61	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	27.67	4.15	6.23	0.69	0.69	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	39.52	4.56	3.42	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	40.80	5.68	7.75	0.52	0.52	0.00	1.03	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	33.26	6.05	7.86	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	34.23	4.75	4.44	0.00	0.32	0.32	0.63	0.00	0.32
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	34.65	5.86	7.46	0.53	1.07	0.00	0.00	0.00	0.53
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	31.03	2.30	4.60	0.57	0.57	0.57	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	44.22	4.11	6.17	0.00	0.51	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	46.69	7.07	6.37	0.71	0.00	0.00	0.71	0.00	0.71
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	32.35	3.97	6.81	0.00	0.57	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	35.78	4.99	5.82	0.83	0.83	0.00	0.42	0.42	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	44.63	10.96	11.75	0.00	0.00	0.00	0.00	0.00	0.78
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	32.57	5.43	5.85	0.42	0.42	0.42	0.00	0.42	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	38.56	2.79	5.11	0.00	0.00	0.00	0.46	0.00	0.93
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	52.19	5.35	5.35	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	37.96	5.88	3.74	0.00	1.60	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	41.62	6.87	6.06	0.40	0.00	0.81	0.40	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	40.38	7.34	7.34	0.00	0.92	0.00	0.00	0.00	0.92
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	43.57	2.67	10.67	0.89	0.00	0.00	0.00	0.00	0.89
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	38.18	7.41	8.55	0.57	0.57	0.57	0.00	0.00	0.57
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	47.55	7.67	6.90	0.00	1.53	0.00	0.77	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	35.02	3.83	5.47	0.00	0.55	0.00	0.00	0.55	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	47.22	5.35	10.25	2.23	0.00	0.00	0.00	0.00	0.45
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	56.41	8.58	12.48	0.00	0.26	0.26	0.26	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	50.40	3.98	6.63	0.00	0.00	0.00	0.66	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	54.04	8.31	2.08	0.00	0.00	0.00	0.00	0.00	0.00
Macrophage - monocyte derived, donor1	11232-116C8	46.72	5.93	5.70	0.00	0.00	0.23	0.46	0.00	0.23
Macrophage - monocyte derived, donor2	11313-117C8	21.47	6.06	4.59	0.00	0.18	0.18	0.00	0.00	0.37
Macrophage - monocyte derived, donor3	11389-118C3	38.93	5.90	6.29	0.00	0.39	0.00	0.13	0.13	0.26
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	15.40	14.87	2.66	0.00	0.00	0.00	0.00	0.00	0.00
Mallassez-derived cells, donor2	11929-125I3	28.52	19.33	6.97	0.63	0.16	0.00	0.00	0.16	1.74
Mallassez-derived cells, donor3	11930-125I4	28.91	9.45	4.45	0.28	0.42	0.00	0.14	0.00	0.56
Mammary Epithelial Cell, donor1	11273-116H4	35.77	21.22	9.47	0.20	0.50	0.00	0.10	0.00	0.10
Mammary Epithelial Cell, donor2	11350-117G9	28.67	12.74	6.37	0.29	0.00	0.00	0.00	0.00	0.29
Mammary Epithelial Cell, donor3	11422-118F9	19.46	26.19	4.49	0.25	0.50	0.00	0.25	0.00	0.25
Mast cell - stimulated, donor1	11487-119E2	8.14	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Mast cell, donor1	11563-120D6	23.03	1.08	0.54	0.00	0.00	0.11	0.22	0.00	0.00
Mast cell, donor2	11565-120D8	31.80	5.65	0.59	0.00	0.30	0.00	0.89	0.00	0.00
Mast cell, donor3	11566-120D9	30.84	5.18	2.03	0.00	0.00	0.23	0.00	0.00	0.23
Mast cell, donor4	11567-120E1	39.18	6.56	1.60	0.00	0.53	0.35	0.71	0.00	0.00
Mast cell, expanded and stimulated, donor5	11940-126A5	34.93	1.55	1.00	0.00	0.11	0.00	0.33	0.00	0.11
Mast cell, expanded and stimulated, donor8	11942-126A7	29.77	0.58	1.17	0.00	0.00	0.00	0.00	0.00	0.00
Mast cell, expanded, donor5	11939-126A4	21.45	1.03	0.23	0.00	0.11	0.11	0.34	0.00	0.00
Mast cell, expanded, donor8	11941-126A6	26.61	2.51	0.33	0.00	0.00	0.00	0.33	0.00	0.17
Melanocyte - dark, donor1	11502-119F8	30.05	4.08	4.38	0.00	0.99	0.10	0.00	0.00	0.10
Melanocyte - dark, donor2	11582-120F7	31.15	32.88	10.73	1.04	0.00	0.00	0.35	0.00	0.35
Melanocyte - dark, donor3	11663-122F7	42.67	110.47	11.95	2.32	0.94	0.07	0.14	0.00	1.59
Melanocyte - light, donor1	11274-116H5	50.54	213.21	17.87	1.88	0.71	1.41	3.29	0.47	1.88
Melanocyte - light, donor2	11351-117H1	55.96	131.72	12.97	0.00	2.05	0.00	0.68	0.00	1.36
Melanocyte - light, donor3	11423-118G1	30.35	112.74	9.54	0.87	0.87	0.87	0.87	0.87	0.87
Melanocyte, donor1 (MC+1)	12641-134G4	45.61	135.88	9.06	1.67	0.73	0.31	0.83	0.42	2.29
Melanocyte, donor2 (MC+2)	12739-135I3	39.00	127.75	6.99	0.27	1.08	0.27	0.54	0.27	1.88
Melanocyte, donor3 (MC+3)	12837-137B2	38.84	102.32	8.30	2.68	0.00	0.00	0.80	0.27	1.34
Meningeal Cells, donor1	11493-119E8	46.03	21.09	15.88	0.87	1.49	0.00	0.12	0.12	0.25
Meningeal Cells, donor2	11573-120E7	33.01	6.16	8.80	0.44	0.88	0.00	0.44	0.44	0.00
Meningeal Cells, donor3	11654-122E7	51.67	20.78	10.76	0.90	1.14	0.08	0.08	0.00	0.49
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	31.08	20.25	9.70	0.00	0.57	0.00	0.00	0.00	0.29
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	52.83	11.87	4.23	0.10	0.60	0.10	0.10	0.10	0.40
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	46.00	36.80	17.08	0.00	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	54.94	19.62	17.01	2.62	2.62	0.00	0.00	0.00	2.62
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	61.71	22.96	14.35	1.44	0.72	0.72	1.44	0.00	1.44
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	43.20	21.81	12.71	0.00	0.64	0.21	0.21	0.00	0.64
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	51.27	20.61	10.05	0.00	0.00	0.50	1.01	0.00	0.50
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	39.12	20.00	15.60	0.22	0.88	0.00	0.00	0.00	0.44
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	35.80	21.92	22.65	0.00	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	47.26	22.30	14.53	1.84	1.02	0.00	0.00	0.00	0.61
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	33.52	13.30	6.37	0.14	0.55	0.28	0.00	0.00	0.14
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	50.93	24.16	18.96	0.37	0.00	0.00	0.74	0.00	1.12
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	50.00	20.79	14.21	1.05	0.39	0.00	0.13	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	49.26	8.01	6.83	0.30	0.30	0.00	0.00	0.00	0.89
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	70.07	16.35	7.01	0.00	0.00	0.00	2.34	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	57.00	16.65	11.53	0.64	0.00	0.00	0.00	0.00	0.64
Mesenchymal stem cells - adipose, donor0	11217-116B2	53.17	26.94	13.82	1.06	1.42	0.00	0.00	0.00	0.71
Mesenchymal stem cells - hepatic, donor0	11218-116B3	37.21	16.89	14.70	0.31	0.63	0.31	0.00	0.00	0.00
Mesenchymal stem cells - umbilical, donor0	11214-116A8	36.28	19.59	15.97	0.00	0.00	0.00	0.00	0.00	0.73
Mesothelial Cells, donor1	11247-116E5	38.45	11.93	3.45	0.00	1.86	0.27	0.00	0.00	0.00
Mesothelial Cells, donor2	12156-128G5	40.54	12.01	0.50	0.00	0.50	0.50	0.00	0.00	0.00
Mesothelial Cells, donor3	11402-118D7	31.65	7.37	2.31	0.29	0.29	0.00	0.07	0.00	0.14
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	37.81	1.35	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	30.29	2.22	4.93	0.00	0.00	0.00	0.25	0.25	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	27.68	5.01	1.77	0.00	0.00	0.29	0.00	0.29	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	13.83	6.91	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	22.32	3.10	2.48	0.31	0.31	0.31	0.00	0.00	0.62
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	21.16	2.90	1.66	0.41	0.00	0.00	0.00	0.00	0.21
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	11.58	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	25.28	1.50	1.50	0.00	0.25	0.00	0.00	0.00	0.25
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	26.53	3.26	4.19	0.00	0.93	0.00	0.00	0.00	1.86
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	38.93	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	31.09	2.03	2.24	0.20	0.20	0.00	0.20	0.00	0.20
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	25.34	3.17	1.98	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	68.41	17.10	8.55	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	31.86	2.65	1.77	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	16.72	4.56	3.42	0.00	0.76	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	9.21	1.32	0.00	0.00	0.00	0.00	0.00	0.00	1.32
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	25.47	2.55	2.76	0.21	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	8.29	1.84	2.76	0.00	0.92	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	30.70	0.89	1.79	0.00	0.30	0.30	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	26.83	0.00	3.35	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	17.81	0.75	1.25	0.00	0.00	0.00	0.25	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	24.24	2.85	1.90	0.24	0.00	0.00	0.00	0.24	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	13.82	1.66	2.21	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	26.71	1.38	2.99	0.00	0.00	0.00	0.00	0.23	0.23
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	20.61	2.10	1.47	0.00	0.21	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	17.53	1.83	1.63	0.20	0.20	0.00	0.20	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	21.24	3.43	1.50	0.64	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	15.56	1.56	1.78	0.22	0.22	0.00	0.00	0.00	0.44
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	10.32	0.00	10.32	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	17.30	2.19	2.41	0.00	0.00	0.00	0.00	0.22	0.66
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	11.15	2.03	1.01	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	16.57	8.28	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	23.37	1.63	2.72	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	13.53	2.35	3.23	0.00	0.00	0.00	0.00	0.00	0.59
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	5.45	0.00	1.09	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	19.22	0.96	1.92	0.00	0.48	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	15.21	0.80	2.80	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	8.23	2.74	0.00	0.00	1.37	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	21.02	1.00	2.00	0.00	1.00	0.50	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	26.95	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	8.15	2.04	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	13.58	3.07	2.19	0.00	0.44	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	19.87	1.10	1.10	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	10.25	1.92	1.92	0.00	0.64	0.00	0.00	0.64	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	21.32	1.24	2.23	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	4.87	0.70	1.39	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	19.89	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	23.93	3.42	1.37	0.00	0.34	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	11.82	1.31	0.44	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	16.69	2.84	2.49	0.00	0.00	0.00	0.00	0.00	0.36
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	14.59	1.96	2.52	0.00	0.28	0.00	0.00	0.00	0.28
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	13.72	1.66	2.08	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	11.07	1.75	1.75	0.00	0.00	1.17	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	19.91	2.71	2.71	0.00	0.90	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	15.86	2.92	2.92	0.00	0.42	0.00	0.00	0.00	0.42
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	21.66	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	16.62	2.77	0.92	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	25.61	3.41	2.28	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	17.00	1.11	2.49	0.14	0.28	0.00	0.00	0.00	0.14
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	15.81	3.11	2.33	0.26	0.52	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	18.87	1.72	2.14	0.00	0.43	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	10.80	3.81	3.18	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	15.48	2.14	1.60	0.27	0.00	0.00	0.00	0.27	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	15.57	2.10	3.29	0.00	0.60	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	16.81	2.26	1.41	0.00	0.42	0.00	0.00	0.00	0.14
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	21.66	2.55	2.23	0.00	0.32	0.00	0.00	0.00	0.32
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	16.58	2.43	2.87	0.00	0.00	0.00	0.00	0.00	0.22
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	15.17	4.55	2.28	0.38	0.00	0.00	0.00	0.38	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	17.90	3.69	1.99	0.00	0.00	0.28	0.28	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	18.68	4.18	3.69	0.00	0.25	0.00	0.00	0.00	0.49
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	8.47	3.91	1.30	0.65	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	17.05	2.06	2.35	0.00	0.00	0.00	0.00	0.00	0.29
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	19.03	2.88	3.17	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	19.78	1.65	1.65	0.00	0.00	0.00	0.41	0.00	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	17.57	2.08	3.87	0.00	0.60	0.00	0.00	0.00	0.30
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	26.37	0.00	0.00	0.00	0.00	0.00	0.00	3.77	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	26.73	3.56	1.78	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	53.23	4.93	3.94	0.33	0.33	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	37.87	4.21	1.05	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	34.60	4.94	5.93	0.20	0.59	0.00	0.20	0.20	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	40.05	6.52	4.66	0.00	1.86	0.00	0.00	0.00	0.93
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	39.06	6.38	6.01	0.38	0.00	0.00	0.00	0.00	0.38
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	26.37	3.46	4.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	37.10	2.60	3.96	0.23	0.90	0.00	0.23	0.11	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	40.52	0.74	1.47	0.00	0.74	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	50.93	3.30	2.93	0.00	0.37	0.00	0.37	0.73	0.37
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	40.45	6.22	4.67	0.00	0.00	0.00	1.56	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	11.76	0.53	1.07	0.00	0.53	0.00	0.00	0.00	0.53
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	27.05	0.00	3.86	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	45.45	9.09	1.01	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	14.76	2.11	2.11	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	4.09	1.36	1.36	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	0.64	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	2.43	0.00	0.00	0.00	0.00	0.00	0.00	0.81	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	3.02	7.55	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	11.42	11.42	5.71	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	13.05	22.84	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	23.76	0.00	4.75	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	12.55	75.29	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	57.74	20.68	11.42	1.51	0.43	0.65	0.22	0.22	0.86
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	38.67	14.11	13.07	0.52	0.52	0.00	0.52	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	23.36	20.02	10.68	0.67	2.00	0.00	0.00	0.00	2.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	26.71	12.52	6.26	0.42	0.00	0.00	0.00	0.42	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	51.91	6.65	8.94	0.38	0.00	0.00	0.38	0.19	0.76
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	33.51	22.34	3.19	0.00	0.00	0.00	0.00	0.00	1.60
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	21.08	21.76	2.72	0.00	2.04	0.00	1.36	0.68	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	62.48	1.84	16.54	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	27.62	15.49	5.02	0.00	0.42	0.00	0.42	0.42	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	31.38	11.62	8.14	0.93	0.23	0.00	0.23	0.46	0.23
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	22.43	11.08	3.24	0.27	0.27	0.00	0.00	0.00	0.27
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	28.80	14.51	6.10	0.63	0.21	0.00	0.21	0.00	0.63
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	66.81	22.27	11.13	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	28.29	9.43	4.47	0.99	0.99	0.00	0.00	0.50	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	23.82	4.33	4.33	0.27	0.27	0.00	0.00	0.27	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	25.16	12.01	2.49	0.23	0.23	0.00	0.68	0.00	0.68
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	27.92	10.94	4.74	0.16	0.16	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	29.16	7.11	3.10	0.18	0.00	0.00	0.18	0.18	0.00
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	25.99	11.67	5.30	0.00	0.53	0.00	0.00	1.59	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	20.41	10.81	6.60	0.60	0.60	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	44.96	2.30	2.63	0.00	0.00	0.00	0.00	0.00	0.33
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	18.38	8.29	1.79	0.33	0.00	0.00	0.16	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	23.46	6.70	2.12	0.00	0.00	0.00	0.18	0.00	0.53
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	17.58	9.14	4.22	0.00	0.00	0.00	0.70	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	25.28	9.65	1.38	0.00	0.46	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	24.74	10.93	2.89	0.00	0.00	0.00	0.00	0.64	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	27.59	2.41	1.03	0.00	0.69	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	42.98	0.00	5.06	0.00	2.53	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	21.16	4.23	3.34	0.00	0.22	0.00	0.00	0.00	0.45
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	22.86	8.47	1.69	0.00	0.00	0.00	0.00	0.42	0.42
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	28.72	5.46	2.61	0.47	0.24	0.00	0.00	0.00	0.24
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	19.32	7.73	2.58	0.00	0.86	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	36.11	9.03	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	21.33	9.33	2.33	1.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	22.54	4.51	3.16	0.00	0.45	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	15.48	12.70	2.38	0.00	0.40	0.40	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	18.57	9.29	3.71	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	21.19	5.68	2.27	0.00	0.00	0.00	0.38	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	16.62	8.47	2.61	0.00	0.00	0.00	0.00	0.33	0.33
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	13.51	6.54	1.74	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	20.35	9.50	4.52	0.45	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	22.05	10.58	6.17	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	22.60	9.97	1.33	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	12.90	9.42	2.98	0.00	0.00	0.00	0.00	0.50	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	15.31	5.74	1.91	0.00	0.38	0.00	0.38	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	35.99	6.05	3.63	0.00	0.00	0.00	0.60	0.00	0.30
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	20.56	5.75	3.54	0.22	0.00	0.00	0.00	0.22	0.22
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	12.20	6.10	1.36	0.00	0.00	0.68	0.68	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	61.31	10.22	0.00	0.00	5.11	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	21.95	8.54	1.83	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	15.42	4.41	2.83	0.63	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	14.22	3.03	2.42	0.00	0.00	0.00	0.30	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	17.41	7.91	4.75	0.79	0.00	0.00	0.00	0.00	0.79
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	57.82	3.40	4.53	0.00	0.00	1.13	2.27	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	60.69	0.00	5.06	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast, donor1	11241-116D8	47.21	19.75	8.07	0.87	0.87	0.12	0.37	0.00	0.50
Myoblast, donor2	11322-117D8	46.60	16.30	8.25	1.15	0.58	0.58	0.38	0.00	0.58
Myoblast, donor3	11398-118D3	49.27	16.65	7.40	0.50	0.50	0.00	0.34	0.00	0.00
NK T cell leukemia cell line:KHYG-1	10777-110G3	61.58	4.09	0.73	0.00	0.29	0.29	0.15	0.00	0.15
Natural Killer Cells, donor1	11230-116C6	12.30	5.54	0.92	0.31	0.00	0.00	0.31	0.00	0.00
Natural Killer Cells, donor2	11311-117C6	8.44	3.32	0.00	0.00	0.00	0.30	0.30	0.00	0.00
Natural Killer Cells, donor3	11387-118C1	14.36	6.26	0.00	0.00	0.00	0.00	0.00	0.37	0.00
Neural stem cells, donor1	11275-116H6	39.56	13.43	5.81	0.36	0.00	0.36	0.36	0.00	0.00
Neural stem cells, donor2	11352-117H2	15.41	5.78	1.93	0.00	0.00	0.00	0.00	0.00	0.00
Neurons, donor1	11494-119E9	9.10	4.55	5.69	1.14	0.00	0.00	0.00	0.00	1.14
Neurons, donor2	11574-120E8	20.48	5.72	4.62	0.22	0.22	0.00	0.00	0.00	0.00
Neurons, donor3	11655-122E8	7.40	8.22	3.29	0.00	0.00	0.00	0.82	0.00	0.00
Neutrophils, donor1	11233-116C9	0.00	0.93	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Neutrophils, donor2	11314-117C9	5.80	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Neutrophils, donor3	11390-118C4	5.50	0.61	0.00	0.00	0.00	0.00	0.61	0.00	0.00
Nucleus Pulposus Cell, donor1	11252-116F1	31.46	8.07	5.34	0.12	0.24	0.00	0.00	0.00	0.24
Nucleus Pulposus Cell, donor2	11409-118E5	32.89	10.42	4.56	0.00	0.00	0.00	0.00	0.00	0.65
Nucleus Pulposus Cell, donor3	11462-119B4	21.06	6.22	3.41	0.00	0.20	0.00	0.00	0.00	0.00
Olfactory epithelial cells, donor1	11933-125I7	20.65	7.02	4.27	0.14	0.00	0.00	0.14	0.00	0.14
Olfactory epithelial cells, donor2	11934-125I8	25.19	14.47	5.21	0.43	0.29	0.29	0.00	0.14	0.14
Olfactory epithelial cells, donor3	11935-125I9	19.64	17.03	4.99	0.23	0.11	0.00	0.11	0.00	0.23
Olfactory epithelial cells, donor4	11936-126A1	24.64	10.81	4.19	0.19	0.29	0.10	0.19	0.00	0.19
Oligodendrocyte - precursors, donor1	11496-119F2	36.71	3.01	4.21	0.00	0.00	0.00	0.60	0.00	0.00
Osteoblast - differentiated, donor1	11276-116H7	31.05	18.29	5.10	0.21	0.64	0.43	0.00	0.21	0.00
Osteoblast - differentiated, donor2	11353-117H3	21.72	20.58	6.86	0.00	0.00	0.00	0.00	0.00	0.00
Osteoblast - differentiated, donor3	11425-118G3	25.45	14.28	2.48	0.00	0.00	0.00	0.62	0.00	0.00
Osteoblast, donor1	11277-116H8	36.55	22.28	10.16	0.20	0.39	0.00	0.00	0.00	0.20
Osteoblast, donor2	11354-117H4	61.80	18.96	8.43	0.70	0.70	0.00	0.00	0.00	0.00
Osteoblast, donor3	11426-118G4	40.17	22.57	11.20	1.24	0.18	0.00	0.00	0.00	0.53
Pancreatic stromal cells, donor1	11249-116E7	32.85	46.41	12.55	0.42	0.59	0.17	0.34	0.25	0.34
Pericytes, donor1	11491-119E6	40.17	6.34	5.12	0.00	0.45	0.11	0.56	0.11	0.22
Pericytes, donor2	11571-120E5	29.20	4.75	4.75	0.00	0.91	0.00	0.45	0.00	0.23
Pericytes, donor3	11652-122E5	43.54	26.45	10.78	0.61	0.61	0.00	0.20	0.00	0.41
Perineurial Cells, donor1	11499-119F5	55.49	21.93	14.92	0.11	1.02	0.00	0.34	0.00	0.68
Perineurial Cells, donor2	11579-120F4	33.40	32.76	14.72	1.10	1.01	0.09	0.28	0.00	0.64
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	19.76	5.42	0.96	0.00	0.00	0.00	0.32	0.00	0.00
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	12.98	1.71	0.24	0.00	0.24	0.00	0.00	0.00	0.00
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	13.46	4.14	1.55	0.00	0.13	0.00	0.00	0.13	0.13
Placental Epithelial Cells, donor1	11278-116H9	24.16	11.48	5.02	0.24	0.48	0.24	0.48	0.00	0.24
Placental Epithelial Cells, donor2	11355-117H5	31.05	15.52	4.44	0.00	0.00	0.00	0.00	0.00	0.00
Placental Epithelial Cells, donor3	11427-118G5	22.97	11.39	2.55	0.00	0.39	0.00	0.00	0.20	0.20
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	40.19	31.96	7.59	1.27	0.63	0.00	0.95	0.63	0.32
Preadipocyte - breast, donor1	11467-119B9	36.39	30.95	7.69	0.56	0.38	0.19	0.38	0.19	0.19
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	74.79	43.99	14.23	1.83	1.44	0.00	0.26	0.00	0.91
Preadipocyte - breast, donor2	11328-117E5	53.81	44.35	6.75	0.90	0.23	0.00	0.45	0.00	0.45
Preadipocyte - omental, donor1	11468-119C1	52.53	45.93	8.84	0.75	1.49	0.21	0.53	0.11	0.64
Preadipocyte - omental, donor2	11329-117E6	46.27	26.19	6.55	0.00	0.44	0.00	0.00	0.44	1.75
Preadipocyte - omental, donor3	11403-118D8	50.57	27.36	7.02	0.57	0.86	0.00	0.14	0.14	0.57
Preadipocyte - perirenal, donor1	11469-119C2	30.51	21.65	5.91	0.98	0.00	0.00	0.98	0.00	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	39.31	19.66	10.44	0.92	0.00	0.00	0.00	0.00	0.00
Preadipocyte - subcutaneous, donor2	11356-117H6	49.58	28.33	15.58	1.59	0.71	0.00	0.18	0.00	0.71
Preadipocyte - subcutaneous, donor3	11428-118G6	56.70	30.14	12.26	0.85	0.68	0.17	0.68	0.00	0.00
Preadipocyte - visceral, donor1	11280-116I2	50.67	19.93	13.13	0.75	0.65	0.09	0.37	0.19	0.47
Preadipocyte - visceral, donor2	11357-117H7	66.27	43.72	19.79	0.92	0.92	0.00	0.00	0.00	0.46
Preadipocyte - visceral, donor3	11429-118G7	41.59	22.26	11.91	0.63	0.73	0.42	0.21	0.00	0.84
Prostate Epithelial Cells (polarized), donor1	11253-116F2	23.68	17.65	11.31	0.30	0.30	0.45	0.60	0.00	0.15
Prostate Epithelial Cells, donor2	11331-117E8	28.17	20.99	3.25	0.68	0.27	0.27	0.81	0.27	0.14
Prostate Epithelial Cells, donor3	11404-118D9	19.53	4.47	1.59	0.06	0.31	0.06	0.43	0.06	0.12
Prostate Stromal Cells, donor1	11254-116F3	45.33	25.40	14.69	1.03	0.46	0.00	0.23	0.11	0.34
Prostate Stromal Cells, donor2	11332-117E9	43.57	39.09	20.62	0.90	0.18	0.00	0.00	0.00	1.08
Prostate Stromal Cells, donor3	11405-118E1	28.26	22.73	8.45	0.83	0.52	0.10	0.52	0.21	0.31
Renal Cortical Epithelial Cells, donor1	11516-119H4	50.00	13.87	10.95	1.09	0.36	0.00	0.36	0.00	0.36
Renal Cortical Epithelial Cells, donor2	11596-120H3	40.96	5.13	6.79	0.62	0.28	0.00	0.21	0.00	0.14
Renal Epithelial Cells, donor1	11517-119H5	61.37	15.22	12.68	0.51	0.51	0.00	0.00	0.51	0.51
Renal Epithelial Cells, donor2	11597-120H4	32.72	15.65	12.80	1.42	0.00	0.00	0.00	0.00	0.00
Renal Epithelial Cells, donor3	11678-122H4	47.43	7.09	8.36	0.42	0.11	0.00	0.11	0.21	0.21
Renal Glomerular Endothelial Cells, donor1	11514-119H2	35.40	20.43	11.57	0.68	0.00	0.00	1.36	0.68	0.68
Renal Glomerular Endothelial Cells, donor2	11594-120H1	41.37	18.06	7.28	0.40	1.21	0.27	0.27	0.00	0.67
Renal Glomerular Endothelial Cells, donor3	11675-122H1	54.61	11.32	8.88	0.67	1.11	0.00	0.44	0.00	0.89
Renal Glomerular Endothelial Cells, donor4	11783-124B1	82.51	17.97	11.98	0.00	0.67	0.00	0.00	0.00	0.00
Renal Mesangial Cells, donor1	11518-119H6	35.87	13.65	10.12	0.22	1.54	0.00	0.00	0.00	0.22
Renal Mesangial Cells, donor2	11598-120H5	33.86	8.15	15.05	0.00	0.63	0.00	0.00	0.00	0.00
Renal Mesangial Cells, donor3	11679-122H5	28.85	8.60	11.37	0.55	0.00	0.00	0.28	0.55	0.28
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	41.34	11.81	7.78	0.27	0.27	0.00	0.00	0.00	0.27
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	26.14	10.54	8.43	0.42	0.00	0.00	0.00	0.00	0.42
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	31.43	8.10	8.68	0.58	0.19	0.00	0.00	0.19	1.35
Retinal Pigment Epithelial Cells, donor0	11215-116A9	29.82	6.22	5.96	0.78	0.00	0.00	0.00	0.00	0.00
Retinal Pigment Epithelial Cells, donor1	11528-119I7	30.41	9.38	5.12	0.28	0.28	0.00	0.57	0.00	0.00
Retinal Pigment Epithelial Cells, donor2	11608-120I6	34.99	6.17	9.26	0.00	0.00	0.00	0.00	0.00	2.06
Retinal Pigment Epithelial Cells, donor3	11689-122I6	38.64	3.51	3.01	0.00	0.50	0.25	0.25	0.00	0.00
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	40.89	12.83	4.94	0.00	0.40	0.27	0.40	0.53	0.40
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	131.33	13.40	10.72	0.00	0.89	0.00	0.00	1.79	1.79
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	129.34	5.50	8.81	1.10	1.10	0.55	0.55	0.55	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	107.89	11.02	8.12	0.58	0.58	0.58	0.58	0.00	0.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	92.06	5.85	8.19	0.26	1.17	0.13	0.00	0.00	0.39
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	105.56	8.74	7.45	0.20	0.30	0.10	0.20	0.00	0.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	117.90	10.93	7.25	0.22	0.67	0.11	0.11	0.22	0.78
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	117.34	8.93	9.43	0.25	0.87	0.25	0.37	0.00	0.50
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	114.10	9.21	8.16	0.47	0.35	0.00	0.70	0.12	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	108.40	8.32	8.78	0.23	0.69	0.23	0.23	0.46	0.92
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	91.87	7.26	6.71	0.27	0.55	0.00	0.14	0.00	0.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	113.45	8.17	6.96	0.30	0.61	0.00	0.00	0.00	0.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	110.38	8.60	9.14	0.72	1.43	0.00	0.18	0.18	0.36
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	98.55	6.46	6.60	0.14	0.72	0.00	0.14	0.00	0.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	117.08	10.84	7.40	0.32	0.75	0.32	0.11	0.00	0.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	103.11	10.84	7.52	0.44	0.89	0.00	0.00	0.22	0.44
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	101.90	6.88	4.97	0.19	0.96	0.00	0.00	0.00	0.76
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	108.81	8.85	7.45	0.56	0.93	0.19	0.19	0.09	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	126.46	8.27	8.08	0.75	0.75	0.19	0.19	0.19	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	91.57	7.17	7.83	0.27	0.80	0.27	0.13	0.13	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	102.31	9.54	7.20	0.19	0.68	0.19	0.10	0.19	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	110.18	8.59	7.07	0.57	1.15	0.19	0.19	0.19	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	97.08	9.08	7.26	0.64	0.64	0.00	0.00	0.00	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	105.39	8.41	5.89	0.28	0.84	0.28	0.84	0.84	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	103.56	9.40	4.96	0.00	0.51	0.17	0.51	0.17	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	93.35	7.48	7.48	0.18	0.91	0.00	0.18	0.00	0.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	103.62	9.93	7.97	0.00	0.74	0.12	0.12	0.49	0.49
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	114.58	8.60	8.33	0.00	1.88	0.67	0.40	0.13	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	115.34	6.37	8.26	0.24	0.71	0.24	0.24	0.00	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	110.32	6.15	5.75	0.40	0.60	0.00	0.40	0.20	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	115.05	9.82	7.95	0.00	0.23	0.00	0.47	0.70	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	99.12	7.46	8.29	0.41	0.21	0.00	0.41	0.00	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	115.91	13.72	7.96	0.00	0.88	0.66	0.22	0.00	0.44
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	104.65	10.65	7.10	0.63	0.63	0.00	0.21	0.21	0.42
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	100.80	8.75	8.08	0.00	0.54	0.00	0.00	0.27	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	103.20	6.64	6.64	0.34	1.02	0.00	0.00	0.17	0.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	89.65	7.33	6.56	0.58	1.16	0.19	0.19	0.19	0.39
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	103.68	7.22	8.25	0.00	0.34	0.00	0.00	0.17	1.03
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	112.75	8.64	8.23	0.41	0.69	0.14	0.14	0.14	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	103.43	10.84	9.19	0.33	1.97	0.00	0.00	0.16	0.16
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	99.19	6.65	6.82	0.00	1.02	0.00	0.17	0.17	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	95.73	10.50	9.03	0.59	0.74	0.15	0.00	0.15	0.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	89.03	9.60	8.26	0.80	0.80	0.27	0.27	0.27	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	109.51	6.50	7.88	0.00	1.24	0.14	0.14	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	113.34	7.38	7.14	0.24	1.19	0.48	0.48	0.00	0.48
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	120.92	8.46	6.85	0.40	0.81	0.00	0.40	0.20	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	118.66	13.75	10.55	0.94	0.94	0.09	0.94	0.28	0.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	166.65	20.61	12.93	0.35	1.05	0.70	1.05	0.70	1.05
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	93.08	12.69	12.39	0.60	0.91	0.00	0.00	0.00	0.91
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	139.64	22.52	11.63	0.00	0.86	0.73	1.84	0.37	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	161.56	26.49	17.18	0.29	1.46	0.15	0.29	0.58	0.29
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	159.41	23.73	12.78	1.22	0.61	0.61	1.22	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	136.53	18.08	12.66	0.30	0.90	0.00	1.81	0.60	0.90
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	259.21	42.75	24.43	1.13	1.36	1.58	8.14	2.04	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	219.26	28.46	18.57	0.60	1.20	0.30	1.20	0.30	1.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	211.12	31.76	24.68	0.12	1.89	2.72	13.11	4.37	1.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	246.32	47.60	19.64	1.49	1.92	2.99	4.27	1.71	0.64
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	171.28	23.44	12.02	0.60	1.80	0.00	0.60	0.60	0.60
Schwann Cells, donor1	11498-119F4	44.01	25.39	15.05	0.56	0.38	0.38	0.19	0.00	0.75
Schwann Cells, donor2	11578-120F3	34.02	13.61	0.00	3.40	0.00	0.00	0.00	0.00	6.80
Schwann Cells, donor3	11659-122F3	34.40	16.87	9.86	0.44	0.00	0.22	0.22	0.00	0.22
Sebocyte, donor1	11220-116B5	29.03	8.22	1.64	0.00	0.55	0.00	0.00	0.00	0.00
Sebocyte, donor2	11301-117B5	27.11	5.51	2.76	0.46	0.00	0.00	0.00	0.00	0.00
Sebocyte, donor3	11378-118B1	23.08	4.53	4.12	0.00	0.00	0.00	0.41	0.00	0.00
Sertoli Cells, donor1	11255-116F4	54.67	28.16	16.57	0.00	1.66	0.00	0.00	0.00	0.00
Sertoli Cells, donor2	11333-117F1	79.08	25.42	8.47	0.00	0.00	0.00	0.00	0.00	0.00
Skeletal Muscle Cells, donor1	11281-116I3	56.22	14.96	11.53	0.35	0.35	0.18	0.62	0.09	0.26
Skeletal Muscle Cells, donor2	11358-117H8	24.58	18.07	5.06	0.00	2.17	0.00	0.00	0.00	0.72
Skeletal Muscle Cells, donor3	11430-118G8	49.33	27.59	9.20	0.00	0.00	0.00	0.00	0.00	0.84
Skeletal Muscle Cells, donor4	11451-119A2	31.26	8.95	9.74	0.31	0.31	0.16	0.00	0.00	0.00
Skeletal Muscle Cells, donor5	11455-119A6	30.77	8.77	10.85	0.45	1.19	0.15	0.00	0.00	0.30
Skeletal Muscle Cells, donor6	11459-119B1	36.01	11.08	12.47	0.92	0.15	0.00	0.00	0.15	0.31
Skeletal Muscle Satellite Cells, donor1	11240-116D7	44.98	10.33	8.95	0.50	0.38	0.13	0.13	0.13	0.00
Skeletal Muscle Satellite Cells, donor2	11321-117D7	31.82	12.13	7.71	0.71	0.14	0.00	0.00	0.00	0.29
Skeletal Muscle Satellite Cells, donor3	11397-118D2	43.35	12.40	9.42	0.69	0.89	0.10	0.00	0.00	0.40
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	45.83	10.78	7.50	0.42	0.59	0.17	0.25	0.08	0.25
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	42.70	14.48	4.34	0.00	0.72	0.72	0.00	0.00	1.45
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	24.91	15.82	9.36	0.83	0.28	0.00	0.00	0.00	0.14
Skin - palm, donor1	10286-104F7	5.37	5.37	2.69	0.00	0.00	0.00	0.00	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	27.25	9.66	1.59	0.14	0.14	0.14	0.00	0.14	0.43
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	64.61	8.18	10.63	0.00	0.00	0.82	0.00	0.00	1.64
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	19.21	8.18	3.76	0.52	0.00	0.00	0.00	0.00	0.52
Small Airway Epithelial Cells, donor1	11256-116F5	30.86	17.24	6.26	0.14	0.97	0.14	0.42	0.00	0.28
Small Airway Epithelial Cells, donor2	11334-117F2	22.65	11.11	4.36	0.14	0.42	0.00	0.14	0.00	0.28
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	67.66	24.32	10.78	0.21	0.85	0.00	0.42	0.42	1.06
Small Airway Epithelial Cells, donor3	11406-118E2	30.65	13.57	4.35	0.07	0.60	0.00	0.22	0.07	0.37
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	12.96	8.95	2.16	0.31	0.00	0.62	0.00	0.00	0.00
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	130.29	99.38	44.91	1.78	2.45	1.11	1.11	0.44	4.67
Smooth Muscle Cells - Aortic, donor0	11210-116A4	32.33	29.98	7.05	0.59	0.00	0.00	0.00	0.00	1.18
Smooth Muscle Cells - Aortic, donor1	11283-116I5	56.35	18.78	12.82	0.88	1.55	0.22	0.22	0.44	0.44
Smooth Muscle Cells - Aortic, donor2	11360-117I1	51.19	23.23	9.06	0.79	0.79	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Aortic, donor3	11432-118H1	24.72	27.81	12.36	1.55	0.77	0.00	0.00	0.00	0.77
Smooth Muscle Cells - Bladder, donor1	11519-119H7	35.03	8.01	6.00	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	54.03	17.97	7.98	0.27	0.93	0.13	0.13	0.00	0.53
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	42.78	20.39	7.54	0.22	0.22	0.44	1.11	0.22	0.22
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	27.14	12.42	3.71	0.38	0.64	0.00	0.00	0.00	0.26
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	32.23	9.12	6.84	0.00	0.33	0.00	0.00	0.33	0.00
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	32.49	12.40	3.54	0.00	0.00	0.00	0.59	0.00	0.30
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	31.75	12.53	3.56	0.43	0.57	0.00	0.14	0.14	0.28
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	41.32	22.77	10.90	0.49	0.33	0.00	0.16	0.16	0.33
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	34.10	14.00	6.70	0.30	0.00	0.00	0.00	0.00	0.30
Smooth Muscle Cells - Carotid, donor1	11285-116I7	47.99	27.78	11.11	0.51	0.76	0.25	0.00	0.00	0.76
Smooth Muscle Cells - Carotid, donor2	11362-117I3	18.36	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	38.15	19.55	10.49	0.00	0.00	0.48	0.95	0.00	0.95
Smooth Muscle Cells - Colonic, donor1	11239-116D6	33.62	16.22	9.14	0.29	0.29	0.00	0.00	0.29	0.29
Smooth Muscle Cells - Colonic, donor2	11320-117D6	31.64	19.16	7.32	0.86	1.08	0.43	0.00	0.00	0.86
Smooth Muscle Cells - Colonic, donor3	11396-118D1	36.00	18.68	9.45	0.52	0.52	0.10	0.21	0.10	0.84
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	53.21	24.59	12.84	0.62	1.08	0.00	0.00	0.62	0.46
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	38.80	15.09	7.55	0.00	1.08	1.08	0.00	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	39.15	16.74	5.98	0.30	0.60	0.00	0.00	0.00	0.60
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	48.14	26.97	24.24	1.02	0.34	0.00	0.34	0.00	1.37
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	35.50	10.92	6.20	0.47	0.55	0.08	0.08	0.00	0.47
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	44.89	19.93	6.14	0.70	0.60	0.20	1.21	0.10	0.30
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	65.99	27.76	9.33	0.46	1.14	0.23	0.46	0.00	0.68
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	39.85	18.11	6.64	0.00	0.60	0.60	1.21	0.00	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	33.38	14.57	12.19	0.26	2.12	0.00	0.00	0.00	0.53
Smooth Muscle Cells - Prostate, donor1	11257-116F6	32.09	27.03	17.58	0.53	0.67	0.27	0.40	0.00	0.80
Smooth Muscle Cells - Prostate, donor2	11335-117F3	58.85	22.04	14.15	0.75	1.25	0.38	1.38	0.50	1.25
Smooth Muscle Cells - Prostate, donor3	11465-119B7	31.71	12.18	4.57	0.25	0.76	0.00	0.51	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	47.04	31.21	12.66	0.60	0.75	0.30	0.30	0.60	0.00
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	42.76	27.76	7.50	0.00	0.00	0.00	0.75	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	37.47	10.34	5.17	0.00	0.00	0.00	1.29	1.29	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	49.30	23.25	5.58	0.93	0.93	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	63.62	17.67	8.58	1.51	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	39.49	14.10	6.58	0.94	0.00	0.00	0.00	0.31	0.63
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	27.43	17.70	7.37	0.00	0.59	0.00	0.29	0.59	0.00
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	18.41	15.00	10.50	0.50	0.83	0.00	0.08	0.00	0.17
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	21.96	9.34	5.14	0.00	0.47	0.00	0.00	0.00	0.47
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	50.95	18.28	7.92	1.73	1.30	0.14	0.00	0.14	0.58
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	34.67	14.28	6.88	1.53	0.25	0.25	0.51	0.25	0.51
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	42.12	16.36	8.46	0.38	0.94	0.00	0.00	0.19	0.56
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	33.82	13.14	10.48	0.56	0.28	0.00	0.00	0.14	0.28
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	49.44	12.07	7.46	0.25	0.59	0.00	0.25	0.00	0.08
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	49.52	12.86	9.05	0.00	0.95	0.00	0.95	0.00	0.48
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	53.83	16.64	5.38	0.49	0.49	0.24	0.00	0.00	0.49
Smooth Muscle Cells - Uterine, donor1	11258-116F7	31.15	30.05	13.70	1.10	0.88	0.22	0.88	0.22	0.22
Smooth Muscle Cells - Uterine, donor3	11466-119B8	34.23	24.87	21.94	2.05	1.46	0.00	0.00	0.00	0.59
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	52.48	22.74	8.36	0.19	0.58	0.00	0.97	0.39	0.58
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	35.44	22.48	8.99	0.53	0.53	0.00	0.79	0.53	0.26
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	28.64	10.41	10.79	0.00	0.74	0.00	0.00	1.12	0.00
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	47.79	20.48	8.62	1.08	0.72	0.00	0.00	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	42.87	15.61	6.81	0.00	0.28	0.00	0.28	0.28	0.28
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	38.21	17.33	10.63	1.18	0.39	0.79	0.39	0.00	0.39
Smooth muscle cells - airway, control, donor1	11966-126D4	39.87	10.41	4.06	0.25	0.00	0.25	0.00	0.00	0.25
Smooth muscle cells - airway, control, donor2	11967-126D5	46.32	13.58	7.19	0.00	0.80	0.40	1.20	0.40	0.00
Smooth muscle cells - airway, control, donor3	11968-126D6	30.10	10.87	5.02	0.00	0.00	0.00	0.42	0.00	0.42
Smooth muscle cells - airway, control, donor4	11969-126D7	30.71	20.17	5.04	0.00	0.00	0.00	0.00	0.00	0.92
Synoviocyte, donor1	11291-117A4	36.86	12.62	2.69	0.34	0.17	0.17	0.17	0.00	0.00
Synoviocyte, donor2	11368-117I9	34.20	14.75	2.85	0.00	0.17	0.00	0.34	0.34	0.34
Synoviocyte, donor3	11440-118H9	30.83	10.05	3.13	0.00	0.00	0.45	0.22	0.00	0.00
Trabecular Meshwork Cells, donor1	11532-120A2	61.82	35.02	13.58	1.43	0.36	0.00	0.00	0.00	0.71
Trabecular Meshwork Cells, donor2	11612-122A1	69.37	21.80	17.84	0.00	0.00	0.00	0.00	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	53.49	28.48	14.36	1.62	1.16	0.00	0.23	0.00	0.46
Tracheal Epithelial Cells, donor1	11292-117A5	24.44	6.09	3.15	0.00	0.14	0.00	0.00	0.00	0.07
Tracheal Epithelial Cells, donor2	11369-118A1	12.37	5.03	3.09	0.00	0.00	0.00	0.39	0.39	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	23.48	8.02	4.01	0.57	0.57	0.00	0.57	0.00	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	51.67	13.41	5.17	0.12	0.25	0.49	0.98	0.25	0.25
Urethra, donor2	10319-105A4	16.19	5.40	1.80	0.00	0.00	0.00	0.00	0.00	0.00
Urothelial Cells, donor1	11520-119H8	40.11	8.24	2.66	0.80	0.80	0.00	0.53	0.00	0.27
Urothelial Cells, donor2	11600-120H7	25.24	8.41	3.20	0.00	0.00	0.00	0.00	0.00	0.00
Urothelial Cells, donor3	11681-122H7	33.92	6.88	2.29	0.00	0.23	0.23	0.00	0.00	0.00
Urothelial cells, donor0	11216-116B1	46.59	9.14	2.23	0.00	0.45	0.22	0.00	0.00	0.22
Whole blood (ribopure), donor090309, donation1	12179-129A1	14.24	2.67	0.00	0.00	0.89	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	10.01	2.86	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	17.11	3.42	2.05	0.00	0.00	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	14.46	4.48	0.69	0.00	0.00	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090325, donation2	12177-128I8	14.53	3.49	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation1	12182-129A4	11.45	4.16	1.04	0.00	0.00	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	16.52	1.84	0.92	0.00	0.92	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	21.91	5.48	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Wilms' tumor cell line:G-401	10809-111A8	18.01	2.71	3.58	0.37	0.00	0.00	0.00	0.00	0.12
Wilms' tumor cell line:HFWT	10597-108E3	19.36	0.88	4.40	0.00	0.88	0.00	0.00	0.00	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	15.36	8.38	2.23	0.00	0.28	0.00	0.00	0.00	0.00
achilles tendon, donor2	10292-104G4	18.60	4.13	4.13	0.00	0.00	0.00	0.00	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	30.59	0.51	1.02	0.25	0.25	0.00	0.00	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	12.31	0.70	0.93	0.00	0.00	0.23	0.00	0.00	0.00
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	12.35	2.14	0.36	0.12	0.12	0.00	0.12	0.00	0.00
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	6.53	1.90	0.82	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	11.24	1.41	0.28	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	24.32	2.75	0.85	0.00	0.00	0.00	0.00	0.21	0.00
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	26.68	14.43	2.72	0.27	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	18.95	7.93	6.61	0.44	0.00	0.00	0.00	0.44	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	29.40	1.23	0.41	0.41	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	23.69	3.49	1.94	0.00	0.78	0.00	0.00	0.78	0.39
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	16.38	2.58	2.76	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	3.90	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	13.94	3.49	1.16	0.00	0.00	0.00	0.00	0.00	0.46
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	14.24	2.07	1.04	0.00	0.00	0.00	0.00	0.00	0.26
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	24.55	1.46	2.05	0.00	0.00	0.00	0.00	0.29	0.00
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	26.03	1.86	3.25	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	62.51	9.05	5.76	0.82	0.41	0.00	0.00	0.00	0.41
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	66.30	11.05	15.35	1.23	1.23	0.00	0.31	0.00	1.23
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	63.15	11.95	13.65	0.00	0.43	0.00	0.00	0.00	0.43
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	49.44	14.56	9.40	1.21	1.21	0.00	0.00	0.00	0.91
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	66.19	11.07	11.79	0.96	0.96	0.00	0.00	0.24	0.24
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	44.99	10.47	4.23	0.45	0.45	0.00	0.00	0.00	0.22
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	22.68	1.67	0.67	0.00	0.33	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	22.30	5.57	1.86	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	7.16	1.51	0.38	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	17.01	0.44	0.44	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	15.00	3.75	0.00	0.00	0.00	0.00	0.00	0.00	0.00
adenocarcinoma cell line:IM95m	10796-110I4	21.19	41.68	3.06	0.24	0.00	0.24	0.00	0.00	0.47
adipose tissue, adult, pool1	10010-101C1	36.61	7.29	5.58	0.16	0.31	0.78	0.47	0.31	0.31
adipose, donor1	10184-103D4	13.49	2.35	7.62	0.59	0.00	0.00	0.00	0.59	0.00
adipose, donor2	10185-103D5	15.00	2.03	7.30	0.00	0.41	0.00	0.41	0.41	0.00
adipose, donor3	10186-103D6	19.06	2.45	8.99	0.27	0.00	0.00	0.54	0.27	0.27
adipose, donor4	10187-103D7	13.00	1.73	4.33	0.00	0.87	0.00	0.00	1.73	1.73
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	33.46	2.68	2.53	0.00	0.00	0.00	0.00	0.00	0.00
adrenal gland, adult, pool1	10081-102A9	14.55	7.28	3.64	0.00	0.00	0.00	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	73.37	13.87	2.27	0.27	0.40	0.00	0.13	0.13	0.13
alveolar cell carcinoma cell line:SW 1573	10708-109H6	45.02	13.22	10.36	0.36	0.36	0.00	0.00	0.00	0.36
amniotic membrane cells, donor1	12235-129G3	30.14	8.35	3.01	0.23	0.23	0.00	0.00	0.00	0.23
amniotic membrane cells, donor2	12236-129G4	38.88	5.07	1.01	0.00	0.00	0.00	0.00	0.34	0.00
amniotic membrane cells, donor3	12237-129G5	20.33	1.18	0.00	0.00	0.00	0.00	0.00	0.00	0.00
amygdala - adult, donor10196	10167-103B5	10.67	1.19	0.00	0.00	0.00	0.00	0.00	0.00	0.00
amygdala, adult, donor10252	10151-102I7	14.19	17.44	3.85	0.81	0.00	0.00	0.00	0.00	0.61
amygdala, newborn, donor10223	10360-105E9	17.75	7.42	0.65	0.00	0.65	0.00	0.00	0.32	0.32
anaplastic carcinoma cell line:8305C	10428-106D5	22.16	5.22	3.31	0.25	0.51	0.00	0.00	0.00	0.13
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	29.12	1.54	1.54	0.22	0.44	0.00	0.00	0.00	0.00
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	6.01	3.01	0.67	0.33	0.00	0.00	0.00	0.00	0.00
aorta, adult, pool1	10052-101G7	16.67	2.94	0.59	0.00	0.00	0.00	0.20	0.00	0.00
appendix, adult	10189-103D9	20.18	14.75	1.55	0.39	0.00	0.00	0.00	0.00	0.00
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	61.56	0.69	4.13	0.00	0.34	0.00	0.00	0.00	0.34
artery, adult	10190-103E1	17.66	0.00	5.43	0.00	0.00	0.00	0.00	0.00	0.00
astrocytoma cell line:TM-31	10425-106D2	24.05	4.93	6.95	0.00	0.14	0.00	0.00	0.14	0.00
b cell line:RPMI1788	10427-106D4	16.21	0.30	0.30	0.00	0.15	0.00	0.00	0.00	0.00
basal cell carcinoma cell line:TE 354.T	10702-109G9	57.71	32.18	8.05	0.00	0.28	0.28	0.00	0.00	0.00
bile duct carcinoma cell line:HuCCT1	10432-106D9	15.08	9.03	3.18	0.30	0.00	0.00	0.00	0.10	0.20
bile duct carcinoma cell line:TFK-1	10496-107C1	3.68	1.17	1.84	0.00	0.00	0.00	0.00	0.00	0.17
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	12.86	1.68	1.12	0.00	0.00	0.00	0.00	0.00	0.00
bladder, adult, pool1	10011-101C2	24.12	6.08	3.59	0.22	0.00	0.11	0.22	0.11	0.11
blood, adult, pool1	10053-101G8	8.86	2.21	0.00	0.00	0.00	0.00	0.00	0.00	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	29.12	6.85	4.28	0.00	0.86	0.00	0.86	0.00	0.00
bone marrow, adult	10192-103E3	26.32	9.45	5.40	0.00	0.67	0.00	0.00	0.00	0.00
brain, adult, donor1	10084-102B3	5.13	24.60	2.05	0.00	0.00	0.00	0.00	0.00	1.03
brain, adult, pool1	10012-101C3	8.24	13.25	2.56	0.33	0.11	0.00	0.11	0.00	0.11
brain, fetal, pool1	10085-102B4	5.34	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	34.69	3.63	1.98	0.00	0.33	0.00	0.00	0.00	0.00
breast carcinoma cell line:MDA-MB-453	10419-106C5	11.36	0.62	0.62	0.00	0.00	0.00	0.00	0.00	0.00
breast, adult, donor1	10080-102A8	42.93	15.15	3.16	0.00	0.63	0.00	0.00	0.00	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	28.08	24.52	9.02	0.38	0.38	0.00	0.13	0.00	0.51
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	13.30	4.95	7.11	0.00	0.00	0.00	0.00	0.00	0.00
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	48.81	3.45	5.76	0.23	0.00	0.46	0.23	0.23	0.00
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	25.42	2.42	1.45	0.00	0.00	0.00	0.00	0.00	0.00
carcinoid cell line:NCI-H1770	10703-109H1	31.03	0.00	2.82	0.47	0.47	0.00	1.41	0.00	0.47
carcinoid cell line:NCI-H727	10735-110B6	19.36	8.75	8.53	0.55	0.22	0.00	0.11	0.00	0.11
carcinoid cell line:SK-PN-DW	10719-109I8	42.78	30.11	5.70	0.00	0.00	0.00	0.63	0.32	0.63
carcinosarcoma cell line:JHUCS-1	10642-109A3	24.22	2.40	2.66	0.27	0.00	0.53	0.27	0.00	0.00
caudate nucleus - adult, donor10196	10177-103C6	1.15	9.21	2.30	1.15	0.00	0.00	0.00	0.00	0.00
caudate nucleus, adult, donor10252	10164-103B2	11.88	10.71	3.85	0.67	0.00	0.00	0.00	0.00	0.50
caudate nucleus, adult, donor10258	10379-105H1	4.58	6.11	0.76	0.00	0.00	0.00	0.00	0.00	0.76
caudate nucleus, newborn, donor10223	10354-105E3	22.71	14.28	7.69	0.73	0.00	0.00	0.00	0.00	0.00
cerebellum - adult, donor10196	10173-103C2	2.91	2.91	0.00	0.00	0.00	0.00	0.00	0.00	0.00
cerebellum, adult, donor10252	10166-103B4	20.07	6.62	3.20	0.00	0.00	0.00	0.00	0.00	0.64
cerebellum, adult, pool1	10083-102B2	6.55	2.41	1.38	0.34	0.00	0.00	0.00	0.00	0.00
cerebellum, newborn, donor10223	10357-105E6	23.25	3.32	4.15	0.00	0.00	0.00	0.00	0.00	0.00
cerebral meninges, adult	10188-103D8	6.81	2.77	2.52	0.25	0.00	0.00	0.00	0.00	0.00
cerebrospinal fluid, donor2	10294-104G6	5.85	7.31	1.46	0.00	0.73	0.00	0.00	0.00	0.00
cervical cancer cell line:D98-AH2	10552-107I3	53.92	7.62	8.77	0.14	0.29	0.00	0.14	0.00	0.14
cervical cancer cell line:ME-180	10553-107I4	6.96	2.49	1.82	0.00	0.00	0.00	0.00	0.00	0.00
cervix, adult, pool1	10013-101C4	25.09	8.61	5.35	0.31	0.42	0.10	0.31	0.00	0.10
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	56.99	9.75	5.43	0.14	0.98	0.00	0.14	0.00	0.00
chondrosarcoma cell line:SW 1353	10700-109G7	44.41	14.37	2.61	0.00	0.00	0.00	0.00	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	39.89	1.86	3.98	0.25	0.75	0.12	0.37	0.00	0.00
choriocarcinoma cell line:SCH	10785-110H2	50.76	2.59	1.85	0.00	0.49	0.12	0.00	0.00	0.00
choriocarcinoma cell line:T3M-3	10618-108G6	41.98	0.71	2.85	0.00	0.24	0.00	0.00	0.00	0.24
chorionic membrane cells, donor1	12238-129G6	70.38	15.10	4.84	0.85	0.85	0.00	0.00	0.00	0.00
chorionic membrane cells, donor2	12239-129G7	68.91	19.49	15.41	1.19	0.89	0.20	0.40	0.70	1.19
chorionic membrane cells, donor3	12240-129G8	92.31	15.94	8.79	0.55	0.55	0.00	1.10	0.00	0.55
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	2.02	1.01	1.01	1.01	0.00	0.00	0.00	0.00	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	24.01	4.99	1.92	0.38	0.19	0.00	0.00	0.00	0.00
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	9.50	4.01	0.63	0.00	0.00	0.00	0.00	0.00	0.21
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	26.96	7.96	5.91	0.26	0.00	0.00	0.00	0.00	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	24.19	10.40	6.77	0.00	0.00	0.00	0.00	0.00	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	25.86	11.20	5.70	0.41	0.61	0.00	0.00	0.00	0.00
chronic myelogenous leukemia cell line:K562	10454-106G4	30.62	24.73	6.48	0.00	0.29	0.00	0.00	0.29	0.00
chronic myelogenous leukemia cell line:KU812	10409-106B4	14.60	1.30	0.52	0.00	0.26	0.00	0.00	0.00	0.00
clear cell carcinoma cell line:JHOC-5	10638-108I8	27.89	2.74	5.49	0.46	0.23	0.23	0.00	0.00	0.23
clear cell carcinoma cell line:TEN	10636-108I6	20.65	3.99	3.99	0.35	0.35	0.00	0.17	0.00	0.17
colon carcinoma cell line:CACO-2	10513-107D9	22.15	10.07	6.96	0.18	0.55	0.00	0.37	0.00	0.37
colon carcinoma cell line:COLO-320	10420-106C6	30.03	0.38	2.66	0.00	0.00	0.00	0.00	0.00	0.38
colon, adult, donor1	10082-102B1	27.37	19.04	2.38	0.00	0.00	0.00	0.00	0.00	0.00
colon, adult, pool1	10014-101C5	26.44	13.28	3.88	0.12	0.12	0.00	0.24	0.00	0.24
colon, fetal, donor1	10070-101I7	17.30	7.42	1.85	0.00	0.00	0.00	0.00	0.00	0.00
common myeloid progenitor CMP, donor1	12130-128D6	32.08	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	50.07	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	20.40	7.65	4.67	0.42	0.00	0.00	0.00	0.00	0.42
cord blood derived cell line:COBL-a 24h infection	10453-106G3	25.96	4.38	3.17	0.00	0.30	0.15	0.00	0.00	0.30
cord blood derived cell line:COBL-a untreated	10449-106F8	26.23	6.63	2.82	0.28	0.14	0.00	0.14	0.00	0.28
corpus callosum, adult, pool1	10042-101F6	21.67	65.90	9.18	2.65	0.11	0.22	0.11	0.00	1.66
cruciate ligament, donor2	10295-104G7	21.07	8.92	3.24	0.00	0.00	0.00	0.00	0.00	0.00
diaphragm, fetal, donor1	10069-101I6	16.05	8.03	3.21	0.00	0.00	0.00	0.00	0.00	0.00
diencephalon, adult	10193-103E4	6.24	12.24	4.56	1.68	0.24	0.24	0.24	0.00	0.24
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	4.82	2.07	0.23	0.00	0.00	0.00	0.00	0.00	0.00
ductal cell carcinoma cell line:KLM-1	10438-106E6	13.33	2.82	2.05	0.00	0.26	0.00	0.00	0.00	0.00
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	45.50	15.65	7.46	0.24	0.48	0.00	0.24	0.00	0.00
ductus deferens, adult	10196-103E7	32.39	4.98	2.99	1.00	0.00	0.00	0.00	0.00	0.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	21.60	10.08	0.00	0.00	1.44	0.00	0.00	0.00	1.44
duodenum, fetal, donor1, tech_rep2	10071-101I8	25.01	8.09	4.41	0.74	0.00	0.00	0.74	0.00	0.74
dura mater, adult, donor1	10041-101F5	30.23	7.02	3.47	0.08	0.33	0.00	0.17	0.00	0.00
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	32.42	2.66	4.44	1.11	0.67	0.67	0.00	0.22	0.22
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	21.21	2.29	3.87	0.29	0.14	0.00	0.14	0.00	0.00
embryonic pancreas cell line:1B2C6	10604-108F1	25.28	4.93	1.85	0.00	0.62	0.00	0.00	0.00	0.62
embryonic pancreas cell line:1C3D3	10605-108F2	27.24	10.29	4.84	0.00	0.30	0.00	0.00	0.00	0.30
embryonic pancreas cell line:1C3IKEI	10606-108F3	27.17	7.72	4.01	0.00	0.00	0.00	0.00	0.00	0.00
embryonic pancreas cell line:2C6	10603-108E9	23.64	11.82	1.31	1.31	0.00	0.00	0.00	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	19.44	1.68	1.68	0.00	0.00	0.00	0.00	0.00	0.00
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	32.98	17.40	6.52	0.36	0.00	0.18	0.18	0.00	1.27
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	17.21	1.77	1.77	0.00	0.16	0.00	0.16	0.00	0.00
epidermoid carcinoma cell line:A431	10426-106D3	17.90	7.45	2.00	0.00	0.11	0.00	0.11	0.00	0.11
epidermoid carcinoma cell line:Ca Ski	10431-106D8	50.37	21.67	7.81	0.11	0.77	0.00	0.00	0.33	0.55
epididymis, adult	10197-103E8	25.12	6.07	5.44	0.21	0.00	0.42	0.42	0.00	0.00
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	40.27	4.97	3.37	0.89	0.18	0.00	0.00	0.00	0.00
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	25.17	3.15	5.90	0.00	0.39	0.00	0.00	0.00	0.39
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	38.27	15.59	4.85	0.13	0.39	0.13	0.13	0.00	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	34.45	15.55	4.63	0.10	0.00	0.00	0.00	0.00	0.10
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	32.49	14.68	6.72	0.45	0.56	0.00	0.00	0.00	0.22
esophagus, adult, pool1	10015-101C6	16.03	5.10	1.91	0.11	0.21	0.00	0.32	0.11	0.11
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	34.31	6.76	4.76	0.50	0.13	0.00	0.00	0.00	0.13
eye - muscle inferior rectus, donor1	10272-104E2	19.32	12.07	7.24	0.00	0.00	0.00	0.00	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	8.42	0.00	0.00	0.00	0.00	0.00	0.00	0.00	2.10
eye - muscle medial, donor2	10299-104H2	14.88	7.44	0.00	0.00	0.00	0.00	0.00	0.00	0.00
eye - muscle superior, donor2	10297-104G9	17.20	11.46	0.00	0.00	0.00	0.00	0.00	0.00	0.00
eye - vitreous humor, donor1	10268-104D7	7.29	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
eye, fetal, donor1	10054-101G9	16.27	2.80	2.80	0.00	0.00	0.51	0.00	0.00	0.00
fibrosarcoma cell line:HT-1080	10758-110E2	42.19	7.44	4.10	0.26	0.26	0.13	0.26	0.13	0.38
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	38.70	4.75	3.80	0.24	0.95	0.24	0.00	0.00	0.47
frontal lobe, adult, pool1	10040-101F4	9.95	9.57	2.44	0.47	0.00	0.00	0.00	0.00	0.19
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	15.61	1.20	1.80	0.00	0.00	0.00	0.00	0.30	0.30
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	77.36	12.62	7.13	0.27	0.37	0.00	0.09	0.00	0.46
gall bladder, adult	10198-103E9	18.11	13.52	6.52	0.24	0.24	0.00	0.24	0.24	0.24
gamma delta positive T cells, donor1	11937-126A2	18.25	19.86	2.15	0.00	0.00	0.00	0.00	0.00	0.00
gamma delta positive T cells, donor2	11938-126A3	24.28	9.71	1.87	0.00	0.00	0.00	0.00	0.00	0.00
gastric adenocarcinoma cell line:MKN1	10614-108G2	61.68	24.50	5.49	0.42	0.84	0.21	0.21	0.00	0.00
gastric adenocarcinoma cell line:MKN45	10612-108F9	22.24	16.83	5.03	0.19	0.00	0.00	0.00	0.00	0.19
gastric cancer cell line:AZ521	10549-107H9	20.17	0.98	0.66	0.00	0.00	0.00	0.00	0.00	0.16
gastric cancer cell line:GSS	10560-108A2	6.41	15.56	3.66	0.00	0.00	0.00	0.00	0.00	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	31.98	0.91	2.28	0.00	0.23	0.00	0.23	0.00	0.46
giant cell carcinoma cell line:LU65	10487-107B1	9.18	11.36	4.82	0.00	0.23	0.00	0.23	0.00	0.00
giant cell carcinoma cell line:Lu99B	10433-106E1	14.00	3.92	1.96	0.14	0.00	0.00	0.14	0.00	0.00
glassy cell carcinoma cell line:HOKUG	10688-109F4	9.73	3.99	1.75	0.00	0.00	0.00	0.00	0.00	0.00
glioblastoma cell line:A172, tech_rep1	10444-106F3	41.27	10.24	4.64	0.32	0.42	0.11	0.00	0.11	0.11
glioblastoma cell line:A172, tech_rep2	10444-106F3	39.46	9.41	4.07	0.56	0.00	0.14	0.00	0.00	0.28
glioblastoma cell line:T98G	10485-107A8	24.39	12.69	8.28	0.22	0.44	0.11	0.11	0.11	0.33
glioma cell line:GI-1	10413-106B8	65.31	12.01	8.49	0.29	0.29	0.00	0.00	0.29	0.00
globus pallidus - adult, donor10196	10175-103C4	5.83	22.60	2.92	1.46	0.00	0.00	0.00	0.00	0.73
globus pallidus, adult, donor10252	10161-103A8	31.98	49.06	7.81	2.93	0.24	0.00	0.24	0.00	1.22
globus pallidus, adult, donor10258	10367-105F7	9.58	27.38	6.85	1.37	0.00	0.00	0.00	0.00	2.74
globus pallidus, newborn, donor10223	10364-105F4	20.78	20.78	4.26	0.53	0.53	0.00	0.00	1.07	0.00
granulocyte macrophage progenitor, donor1	12131-128D7	53.84	7.34	12.24	0.00	2.45	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	0.00	0.00	0.00	0.00	10.93	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	10.45	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	19.52	2.56	2.56	0.64	0.32	0.00	0.00	0.00	0.00
hIPS +CCl2, biol_rep1	14383-156B9	13.77	2.30	7.80	0.00	0.00	0.00	0.00	0.00	0.00
hIPS +CCl2, biol_rep2	14384-156C1	12.35	2.29	5.03	0.46	0.00	0.00	0.00	0.00	0.00
hIPS +CCl2, biol_rep3	14385-156C2	21.90	0.64	3.22	0.00	0.00	0.00	0.00	0.00	0.00
hIPS, biol_rep1	14380-156B6	24.43	1.44	5.75	0.00	0.00	0.00	0.00	1.44	0.00
hIPS, biol_rep2	14381-156B7	13.72	1.37	5.49	0.00	0.00	0.00	0.00	0.00	0.00
hIPS, biol_rep3	14382-156B8	3.31	6.62	3.31	0.00	0.00	0.00	0.00	0.00	0.00
hairy cell leukemia cell line:Mo	10712-109I1	19.25	0.00	1.72	0.00	0.00	0.00	0.29	0.00	0.00
heart - mitral valve, adult	10205-103F7	23.02	9.27	2.39	0.00	0.30	0.00	0.00	0.00	0.90
heart - pulmonic valve, adult	10206-103F8	19.87	3.92	2.61	0.00	0.26	0.00	0.00	0.00	0.00
heart - tricuspid valve, adult	10207-103F9	34.14	22.48	11.66	0.00	0.83	0.00	0.83	0.00	0.00
heart, adult, diseased post-infarction, donor1	10050-101G5	13.47	2.24	1.84	0.00	0.20	0.00	0.00	0.00	0.00
heart, adult, diseased, donor1	10051-101G6	29.38	3.83	2.98	0.00	0.00	0.00	0.00	0.00	0.00
heart, adult, pool1	10016-101C7	27.83	6.44	4.37	0.00	0.23	0.23	0.00	0.00	0.00
heart, fetal, pool1	10046-101G1	34.40	6.67	4.72	0.21	0.00	0.00	0.00	0.00	0.00
hepatic mesenchymal tumor cell line:LI90	10778-110G4	47.20	22.52	7.40	0.62	0.00	0.00	0.31	0.31	0.00
hepatoblastoma cell line:HuH-6	10633-108I3	14.27	17.84	7.14	1.19	0.00	0.00	0.00	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	32.49	21.44	10.72	1.44	0.44	0.00	0.00	0.11	1.33
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	33.74	24.88	11.77	1.58	0.24	0.00	0.12	0.12	1.21
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	36.68	23.75	12.53	1.52	0.20	0.20	0.00	0.00	0.51
hepatoma cell line:Li-7	10484-107A7	35.59	3.78	4.56	0.33	0.44	0.00	0.11	0.00	0.22
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	6.23	0.10	0.30	0.00	0.10	0.00	0.00	0.00	0.00
hippocampus - adult, donor10196	10169-103B7	3.79	4.73	1.89	0.00	0.00	0.00	0.00	0.00	0.00
hippocampus, adult, donor10252	10153-102I9	21.23	22.66	5.71	0.82	0.00	0.20	0.00	0.00	1.22
hippocampus, adult, donor10258	10374-105G5	3.98	5.98	3.49	0.00	0.00	0.00	0.00	0.00	0.50
hippocampus, newborn, donor10223	10363-105F3	8.11	7.75	2.82	0.00	0.00	0.00	0.35	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	23.19	1.83	4.88	0.00	0.00	0.00	0.61	0.00	0.61
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	25.13	1.96	4.32	0.00	0.59	0.00	0.20	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	25.90	1.27	6.09	0.51	0.25	0.00	0.25	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	11.28	3.38	16.35	0.00	0.00	0.00	1.13	0.56	0.56
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	11.88	5.42	17.56	1.03	0.26	1.03	1.03	0.77	0.77
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	13.29	2.66	16.32	0.00	0.00	1.14	0.76	0.76	0.38
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	14.01	3.80	8.76	0.58	0.29	0.00	1.17	0.58	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	15.73	3.45	12.49	0.22	0.00	0.22	0.65	0.86	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	22.10	3.34	10.84	0.42	0.00	0.83	0.00	1.25	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	9.95	7.58	6.87	0.71	0.00	0.24	0.00	0.47	0.71
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	14.46	7.07	8.52	0.48	0.16	0.32	0.16	0.32	0.48
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	17.51	3.37	6.06	0.00	0.00	0.00	0.00	0.00	0.67
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	22.53	1.72	4.38	0.16	0.16	0.31	0.00	0.31	0.16
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	20.63	0.98	3.93	0.49	0.00	0.00	0.49	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	21.82	0.87	7.85	0.00	0.00	0.00	0.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	10.50	5.35	22.34	0.38	0.00	0.38	0.76	0.38	0.38
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	13.95	3.49	19.62	0.00	0.00	0.44	1.31	0.44	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	18.49	0.50	25.99	0.00	0.00	0.00	0.50	0.50	0.50
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	8.10	3.20	8.29	0.19	0.00	0.19	0.57	0.38	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	10.46	4.55	10.91	0.45	0.00	0.45	0.91	0.00	0.45
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	14.10	1.88	10.02	0.00	0.00	0.00	0.63	1.25	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	14.37	5.88	6.04	0.33	0.16	0.16	0.33	0.33	0.16
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	14.23	6.39	7.26	0.29	0.00	0.00	0.58	0.87	0.29
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	21.22	4.48	8.97	0.00	0.60	0.00	0.30	0.30	0.30
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	27.16	2.22	7.21	0.55	0.37	0.55	0.18	0.00	0.37
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	21.68	2.85	7.99	0.29	0.29	0.29	0.29	0.00	0.57
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	26.95	1.63	9.39	0.82	0.00	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	14.79	4.58	10.21	0.00	0.35	0.35	0.70	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	16.47	4.12	12.04	0.63	0.63	0.00	0.32	0.32	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	21.79	2.72	16.64	0.91	0.00	0.00	0.91	0.61	1.82
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	16.03	3.62	11.38	0.00	0.52	0.52	1.03	0.52	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	7.97	4.65	3.32	0.00	0.00	0.00	0.66	0.00	1.33
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	13.08	1.28	8.98	0.26	0.26	0.00	0.51	0.26	0.26
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	19.17	11.50	9.97	1.28	0.77	0.00	0.51	0.77	0.51
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	13.63	10.60	8.33	0.00	0.00	0.00	0.00	0.76	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	29.57	15.46	8.74	1.68	1.01	0.34	0.34	0.00	0.34
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	24.88	2.66	6.04	0.00	0.00	0.24	0.24	0.00	0.24
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	28.08	2.23	5.79	0.45	0.89	0.00	0.89	0.45	0.45
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	26.83	2.44	11.22	0.98	0.00	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	14.67	3.06	15.89	0.31	0.00	0.61	0.00	0.92	1.22
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	6.51	0.00	6.51	0.00	0.00	0.00	6.51	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	16.55	3.31	20.19	1.32	0.00	0.33	0.99	0.99	0.33
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	6.57	2.19	9.30	0.55	0.00	0.00	0.00	0.00	0.55
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	13.75	1.09	6.51	1.09	0.00	0.36	0.36	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	9.61	3.20	7.83	0.36	0.00	0.36	0.00	0.00	0.36
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	21.48	4.77	9.55	0.00	0.00	0.00	0.00	0.00	1.19
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	15.17	4.06	10.43	0.54	0.27	0.14	0.68	0.27	0.14
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	19.67	2.69	7.54	0.54	0.27	0.27	0.00	0.00	0.27
immature langerhans cells, donor1	11904-125F5	6.54	2.18	0.73	0.00	0.00	0.00	0.00	0.00	0.00
immature langerhans cells, donor2	11905-125F6	3.17	1.58	0.79	0.00	0.00	0.00	0.00	0.00	0.79
insula, adult, pool1	10039-101F3	9.46	11.26	3.88	0.00	0.00	0.00	0.09	0.00	0.38
keratoacanthoma cell line:HKA-1	10791-110H8	10.73	20.81	1.63	0.00	0.00	0.00	0.00	0.00	0.00
kidney, adult, pool1	10017-101C8	35.45	6.31	4.81	0.40	0.10	0.10	0.10	0.00	0.10
kidney, fetal, pool1	10045-101F9	30.84	5.66	4.88	0.28	0.28	0.00	0.21	0.14	0.07
large cell lung carcinoma cell line:IA-LM	10509-107D5	60.50	7.95	5.11	0.28	0.00	0.14	0.14	0.14	0.14
large cell lung carcinoma cell line:NCI-H460	10839-111E2	62.49	49.49	8.16	0.28	0.69	0.00	0.28	0.28	0.55
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	9.54	8.26	1.83	0.00	0.18	0.00	0.00	0.00	0.18
left atrium, adult, donor1	10079-102A7	18.52	3.27	1.09	0.54	0.00	0.00	1.09	0.00	0.00
left ventricle, adult, donor1	10078-102A6	13.65	4.55	2.02	0.51	0.00	0.51	0.00	0.00	0.00
leiomyoblastoma cell line:G-402	10721-110A1	15.60	6.29	6.84	0.00	0.00	0.00	0.00	0.00	0.00
leiomyoma cell line:10964C	10569-108B2	58.20	40.60	14.01	1.44	1.08	0.00	0.36	0.36	1.08
leiomyoma cell line:15242A	10570-108B3	46.74	28.80	9.24	0.00	0.00	0.54	0.54	0.54	1.09
leiomyoma cell line:15425	10571-108B4	56.82	26.95	12.87	0.97	0.73	0.24	0.49	0.00	0.49
leiomyosarcoma cell line:Hs 5.T	10722-110A2	19.05	19.05	0.00	0.00	0.00	0.00	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	44.96	6.27	7.32	1.05	2.09	0.00	0.00	0.00	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	29.28	8.74	1.77	0.12	0.12	0.00	0.00	0.00	0.00
liposarcoma cell line:KMLS-1	10782-110G8	55.92	18.59	10.62	0.62	0.16	0.00	0.00	0.16	0.31
liposarcoma cell line:SW 872	10726-110A6	38.62	21.32	11.45	1.10	0.37	0.00	0.12	0.37	1.22
liver, adult, pool1	10018-101C9	80.22	6.81	7.29	0.32	1.46	0.49	0.97	0.32	0.32
liver, fetal, pool1	10086-102B5	14.11	2.82	1.88	0.00	0.00	0.00	0.00	0.00	0.00
locus coeruleus - adult, donor10196	10182-103D2	11.37	27.12	2.62	0.15	0.00	0.00	0.00	0.00	0.44
locus coeruleus, adult, donor10252	10165-103B3	23.62	36.73	4.43	2.03	0.18	0.00	0.18	0.00	0.37
locus coeruleus, adult, donor10258	10375-105G6	17.21	22.29	3.10	0.85	0.00	0.00	0.28	0.28	0.85
locus coeruleus, newborn, donor10223	10362-105F2	23.55	6.73	3.79	0.84	0.00	0.00	0.42	0.42	1.26
lung adenocarcinoma cell line:A549	10499-107C4	24.08	1.66	2.35	0.14	0.14	0.00	0.00	0.00	0.00
lung adenocarcinoma cell line:PC-14	10408-106B3	17.92	6.20	0.69	0.00	0.00	0.00	0.00	0.00	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	21.09	2.90	3.56	0.00	0.00	0.13	0.13	0.00	0.13
lung, adult, pool1	10019-101D1	30.59	4.25	3.07	0.24	0.24	0.00	0.12	0.00	0.24
lung, fetal, donor1	10068-101I5	26.54	6.85	4.00	0.00	0.57	0.00	0.00	0.00	0.00
lung, right lower lobe, adult, donor1	10075-102A3	30.70	6.42	4.12	0.92	0.00	0.46	0.00	0.00	0.00
lymph node, adult, donor1	10077-102A5	27.93	1.89	2.37	0.00	0.95	0.00	0.00	0.47	0.00
lymphangiectasia cell line:DS-1	10727-110A7	27.18	1.53	0.88	0.00	0.22	0.00	0.00	0.00	0.00
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	12.53	0.00	0.00	0.00	0.30	0.00	0.00	0.00	0.00
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	15.29	6.80	0.85	0.00	0.85	0.00	0.00	0.00	0.00
mature adipocyte, donor1	12231-129F8	15.54	1.78	4.44	0.00	0.00	0.00	0.00	0.00	0.00
mature adipocyte, donor2	12232-129F9	22.62	3.53	1.66	0.21	0.21	0.00	0.00	0.00	0.00
mature adipocyte, donor3	12233-129G1	17.78	2.84	1.90	0.00	0.24	0.00	0.00	0.00	0.00
mature adipocyte, donor4	12234-129G2	16.32	2.90	2.11	0.00	0.26	0.00	0.00	0.00	0.26
maxillary sinus tumor cell line:HSQ-89	10414-106B9	37.64	3.81	4.53	0.48	0.24	0.00	0.24	0.00	0.00
medial frontal gyrus - adult, donor10196	10170-103B8	9.02	1.13	1.13	0.00	1.13	0.00	0.00	0.00	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	16.55	17.84	4.05	0.92	0.00	0.00	0.00	0.00	0.55
medial frontal gyrus, adult, donor10258	10368-105F8	6.35	5.40	1.27	0.00	0.00	0.32	0.00	0.00	0.00
medial frontal gyrus, newborn, donor10223	10352-105E1	10.66	5.12	2.13	0.00	0.00	0.00	0.00	0.00	0.00
medial temporal gyrus - adult, donor10196	10183-103D3	8.78	6.24	2.70	0.17	0.17	0.00	0.00	0.00	0.17
medial temporal gyrus, adult, donor10252	10156-103A3	19.31	22.28	5.31	0.85	0.00	0.21	0.21	0.00	0.64
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	3.85	3.85	0.00	0.00	0.00	0.00	0.00	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	0.00	14.35	0.00	0.00	0.00	0.00	0.00	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	12.56	3.59	2.15	0.36	0.00	0.00	0.00	0.00	0.00
medulla oblongata - adult, donor10196	10174-103C3	11.68	19.47	3.24	0.65	0.00	0.00	0.65	0.65	1.30
medulla oblongata, adult, donor10252	10155-103A2	26.94	38.70	5.11	1.39	0.00	0.00	0.00	0.31	0.31
medulla oblongata, adult, pool1	10038-101F2	15.02	27.83	4.00	1.22	0.16	0.08	0.00	0.00	0.90
medulla oblongata, newborn, donor10223	10361-105F1	24.30	20.48	7.64	1.39	0.00	0.00	0.35	0.35	0.69
medulloblastoma cell line:D283 Med	10838-111E1	14.61	0.89	1.33	0.00	0.22	0.00	0.00	0.00	0.00
medulloblastoma cell line:ONS-76	10759-110E3	43.77	14.67	7.34	0.00	0.24	0.00	0.00	0.24	0.98
melanoma cell line:COLO 679	10514-107E1	38.96	125.63	13.80	4.17	0.72	0.43	1.44	0.29	2.59
melanoma cell line:G-361	10465-106H6	61.62	253.00	19.82	3.26	1.90	1.63	3.26	0.81	2.17
meningioma cell line:HKBMM	10691-109F7	41.43	23.88	10.85	0.18	0.90	0.36	0.00	0.54	0.18
merkel cell carcinoma cell line:MKL-1	10843-111E6	10.57	0.00	0.88	0.00	0.00	0.00	0.00	0.00	0.00
merkel cell carcinoma cell line:MS-1	10844-111E7	8.81	4.15	2.59	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal precursor cell - adipose, donor1	11747-123G1	42.81	19.95	13.04	0.77	0.31	0.15	0.15	0.00	0.15
mesenchymal precursor cell - adipose, donor2	11748-123G2	47.63	14.00	10.00	0.36	1.09	0.00	0.36	0.18	0.73
mesenchymal precursor cell - adipose, donor3	11749-123G3	39.75	28.57	13.67	2.07	1.24	0.00	0.41	0.00	1.24
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	45.09	11.94	3.79	0.14	0.42	0.14	0.14	0.14	0.14
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	38.51	10.98	2.12	0.19	0.58	0.00	0.00	0.00	0.00
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	66.63	12.49	5.55	0.00	0.00	0.69	0.00	0.00	0.69
mesenchymal precursor cell - cardiac, donor1	11752-123G6	48.06	19.57	7.04	0.34	1.20	0.00	0.34	0.00	0.86
mesenchymal precursor cell - cardiac, donor2	11753-123G7	35.88	12.42	5.18	0.35	0.35	0.12	0.23	0.12	0.46
mesenchymal precursor cell - cardiac, donor3	11754-123G8	42.71	16.45	10.08	0.80	0.66	0.40	0.13	0.00	0.27
mesenchymal precursor cell - cardiac, donor4	11755-123G9	42.94	15.66	8.24	0.14	0.68	0.00	0.14	0.00	0.54
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	44.67	13.09	6.83	0.14	0.14	0.14	0.14	0.28	0.57
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	59.28	12.84	8.23	0.66	0.99	0.00	0.33	0.33	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	38.61	13.70	4.84	0.28	1.52	0.00	0.00	0.00	0.55
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	54.46	52.01	16.06	2.09	1.40	0.35	0.35	0.00	1.40
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	53.29	28.99	13.27	0.41	1.84	0.61	0.41	0.00	1.02
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	49.25	17.97	13.30	0.36	0.36	0.36	0.72	0.00	1.08
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	70.45	17.59	8.79	0.31	0.83	0.21	0.93	0.00	0.31
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	59.51	13.22	4.79	0.46	0.23	0.23	0.46	0.23	0.23
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	46.57	13.01	7.13	1.26	0.00	0.42	0.42	0.00	0.84
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	40.35	16.44	9.12	0.60	0.30	0.00	0.45	0.00	0.15
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	44.20	11.99	7.88	0.53	0.44	0.18	0.00	0.09	0.53
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	53.75	14.36	6.63	0.74	0.37	0.00	0.00	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	56.09	18.31	8.01	0.57	0.86	0.29	0.57	0.29	0.00
mesenchymal stem cell line:Hu5/E18	10568-108B1	30.73	9.26	7.58	0.00	0.42	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	33.34	18.72	12.33	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	38.88	21.23	9.21	0.51	0.00	0.26	0.26	0.00	0.51
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	41.88	19.89	13.09	0.52	0.79	0.00	0.00	0.00	0.52
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	45.29	22.49	8.32	0.62	0.62	0.31	0.00	0.31	1.54
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	35.77	23.30	6.83	0.47	0.24	0.00	0.24	0.00	0.47
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	40.95	23.35	8.80	0.00	0.00	0.34	0.34	0.00	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	36.15	23.19	9.82	0.79	0.79	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	31.97	26.88	11.58	0.00	0.46	0.00	0.00	0.00	0.46
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	96.61	48.30	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	44.99	24.52	11.25	1.15	0.29	0.00	0.29	0.29	0.58
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	40.83	24.09	8.25	0.67	0.45	0.00	0.22	0.22	0.22
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	37.49	26.92	9.85	0.48	0.48	0.24	0.00	0.24	0.24
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	31.53	17.60	8.07	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	42.96	27.19	9.06	1.34	0.00	0.34	0.67	0.34	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	40.53	18.83	7.37	0.00	0.00	0.41	1.23	0.00	0.41
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	37.80	20.19	11.60	0.00	0.00	0.00	0.00	0.00	1.29
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	30.08	21.88	16.41	2.73	2.73	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	51.65	51.65	10.33	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	34.10	21.11	8.44	0.32	0.97	0.65	0.32	0.00	0.32
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	43.65	26.19	7.27	0.00	0.00	0.00	1.45	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	35.72	25.59	10.66	0.00	0.00	0.00	0.00	0.53	1.60
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	29.44	34.35	11.45	0.00	0.82	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	29.54	23.32	10.50	0.39	0.78	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	46.17	27.28	2.10	2.10	2.10	0.00	0.00	2.10	2.10
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	32.78	22.85	9.93	0.99	0.00	0.00	0.99	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	47.67	38.14	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	32.61	22.53	10.08	0.00	0.00	0.00	0.00	0.00	0.59
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	46.30	23.15	7.31	0.00	0.00	0.00	0.00	1.22	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	27.05	0.00	0.00	0.00	0.00	0.00	0.00	0.00	27.05
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	38.64	27.87	4.43	0.63	0.00	0.00	0.00	0.00	0.63
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	37.25	24.14	11.04	0.34	0.34	0.00	0.69	0.34	1.03
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	15.04	6.45	6.45	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	43.91	27.94	15.97	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	68.88	24.11	3.44	3.44	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	52.97	21.19	7.74	0.41	0.41	0.41	0.81	0.41	0.41
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	57.99	23.04	12.71	0.79	0.00	0.00	1.59	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	37.14	11.79	7.66	0.00	0.59	0.00	1.18	0.00	0.59
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	48.00	18.08	5.92	0.31	0.31	0.00	0.31	0.00	0.62
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	49.46	24.06	2.67	0.00	0.00	0.00	0.00	0.00	1.34
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	44.94	7.10	4.73	0.00	1.18	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	48.79	12.84	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	35.11	8.26	10.33	0.00	0.00	0.00	0.69	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	35.63	6.93	3.96	0.00	0.49	0.49	0.00	0.00	0.49
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	21.31	4.49	2.24	0.00	1.12	0.00	0.00	0.00	1.12
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	37.53	5.72	4.45	0.00	0.00	0.00	0.00	0.64	0.64
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	27.00	5.64	3.63	0.00	0.00	0.00	0.00	0.00	0.40
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	28.35	10.90	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	22.81	10.14	1.27	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	24.28	4.25	5.46	0.61	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	40.67	4.52	4.52	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	27.18	5.77	2.47	0.00	1.65	0.00	0.82	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	18.06	8.14	3.77	0.40	0.20	0.00	0.00	0.00	0.20
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	24.01	10.71	3.89	0.32	0.00	0.00	0.32	0.32	0.32
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	32.60	18.34	2.04	0.00	0.00	0.00	0.00	0.00	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	36.36	3.09	2.32	0.00	0.77	0.00	0.00	0.00	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	52.21	4.72	3.07	0.00	0.47	0.00	0.00	0.24	0.47
mesothelioma cell line:ACC-MESO-4	10494-107B8	53.05	13.67	7.88	0.23	0.70	0.00	0.00	0.23	0.70
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	34.19	8.55	4.27	0.00	4.27	0.00	0.00	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	36.58	6.27	3.60	0.31	0.72	0.00	0.21	0.10	0.62
mesothelioma cell line:Mero-25	10850-111F4	41.53	4.09	6.13	0.45	0.91	0.00	0.23	0.00	0.45
mesothelioma cell line:Mero-41	10851-111F5	49.14	13.69	7.09	1.22	0.49	0.24	0.49	0.49	0.49
mesothelioma cell line:Mero-48a	10852-111F6	38.53	12.40	3.99	0.22	0.00	0.22	0.22	0.00	0.66
mesothelioma cell line:Mero-82	10853-111F7	33.90	14.98	8.41	0.53	0.53	0.26	0.79	0.00	0.00
mesothelioma cell line:Mero-83	10854-111F8	26.38	6.81	2.04	0.00	0.17	0.17	0.17	0.34	0.00
mesothelioma cell line:Mero-84	10855-111F9	67.49	18.96	6.82	0.76	0.76	0.25	0.51	0.00	0.25
mesothelioma cell line:Mero-95	10856-111G1	36.23	13.25	3.93	0.41	0.41	0.41	0.21	0.00	0.00
mesothelioma cell line:NCI-H2052	10847-111F1	11.43	5.63	4.14	0.17	0.17	0.00	0.00	0.00	0.83
mesothelioma cell line:NCI-H226	10846-111E9	26.42	13.57	5.79	0.72	0.36	0.00	0.00	0.18	0.00
mesothelioma cell line:NCI-H2452	10848-111F2	28.70	9.57	4.44	0.51	0.17	0.00	0.34	0.00	0.00
mesothelioma cell line:NCI-H28	10845-111E8	23.41	1.53	0.76	0.25	0.25	0.00	0.25	0.00	0.00
mesothelioma cell line:No36	10857-111G2	47.30	8.48	7.50	0.65	0.00	0.00	0.00	0.00	0.00
mesothelioma cell line:ONE58	10858-111G3	32.79	20.32	6.77	1.08	0.00	0.00	0.54	0.00	0.00
migratory langerhans cells, donor1	11901-125F2	6.14	2.11	0.96	0.19	0.00	0.00	0.00	0.00	0.00
migratory langerhans cells, donor2	11902-125F3	8.30	2.69	1.59	0.12	0.12	0.00	0.00	0.00	0.12
migratory langerhans cells, donor3	11903-125F4	8.44	1.97	0.90	0.18	0.00	0.00	0.00	0.00	0.18
mixed mullerian tumor cell line:HTMMT	10689-109F5	140.06	22.20	16.32	0.98	0.33	0.33	0.65	0.33	1.31
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	14.84	2.76	1.91	0.42	0.00	0.00	0.00	0.00	0.21
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	10.60	12.67	2.76	0.00	0.23	0.00	0.00	0.00	0.00
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	6.28	1.33	0.95	0.19	0.00	0.00	0.00	0.00	0.00
myelodysplastic syndrome cell line:SKM-1	10772-110F7	37.70	3.51	2.96	0.00	0.18	0.00	0.55	0.00	0.00
myeloma cell line:PCM6	10474-106I6	122.75	22.14	7.31	0.00	1.58	0.79	1.19	0.40	0.40
myxofibrosarcoma cell line:MFH-ino	10600-108E6	27.39	8.62	5.07	0.00	0.00	0.00	0.00	0.00	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	47.66	22.95	8.43	1.77	0.39	0.20	0.00	0.00	0.20
nasal epithelial cells, donor1, tech_rep1	12226-129F3	23.84	7.24	1.78	0.22	0.33	0.00	0.00	0.11	0.00
nasal epithelial cells, donor1, tech_rep2	12226-129F3	24.34	4.12	2.72	0.00	0.29	0.00	0.00	0.07	0.15
nasal epithelial cells, donor2	12227-129F4	23.18	3.86	1.66	0.00	0.00	0.00	0.00	0.00	0.00
neuroblastoma cell line:CHP-134	10508-107D4	10.58	1.15	3.22	0.00	0.00	0.00	0.00	0.00	0.00
neuroblastoma cell line:NB-1	10539-107G8	38.35	4.12	6.74	1.12	0.37	0.00	0.00	0.19	0.00
neuroblastoma cell line:NBsusSR	10607-108F4	8.86	10.33	12.23	1.27	0.00	0.00	0.21	0.00	1.05
neuroblastoma cell line:NH-12	10555-107I6	23.11	2.98	3.35	0.19	0.19	0.00	0.19	0.00	0.00
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	13.76	20.88	7.59	0.71	0.24	0.00	0.00	0.00	0.95
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	9.34	16.00	7.60	0.16	0.00	0.00	0.00	0.16	0.16
neuroectodermal tumor cell line:TASK1	10774-110F9	24.75	7.04	3.02	0.00	0.40	0.20	0.00	0.00	0.00
neuroepithelioma cell line:SK-N-MC	10728-110A8	6.36	19.07	1.91	0.64	0.00	0.00	0.00	0.00	0.64
neurofibroma cell line:Hs 53.T	10729-110A9	34.60	24.49	9.58	0.27	0.80	0.00	0.00	0.27	0.53
neutrophil PMN, donor1	12133-128D9	29.75	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	13.28	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	9.47	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	29.93	0.68	0.17	0.00	0.34	0.00	0.00	0.00	0.00
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	68.04	5.60	4.80	0.00	0.00	0.00	0.00	0.00	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	34.63	23.40	12.50	1.28	0.64	0.00	1.92	0.32	0.64
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	49.40	17.08	13.40	0.26	1.05	0.26	0.00	0.00	0.00
nucleus accumbens, adult, pool1	10037-101F1	7.41	11.53	2.81	0.28	0.19	0.00	0.00	0.09	0.37
occipital cortex - adult, donor10196	10172-103C1	8.24	12.36	0.00	2.06	0.00	0.00	0.00	0.00	0.00
occipital cortex, adult, donor10252	10163-103B1	25.76	36.23	6.17	0.54	0.00	0.00	0.27	0.27	0.81
occipital cortex, newborn, donor10223	10355-105E4	12.37	4.73	4.00	0.36	0.36	0.00	0.00	0.00	0.73
occipital lobe, adult, donor1	10076-102A4	7.08	12.07	1.57	0.26	0.00	0.00	0.00	0.00	0.26
occipital lobe, fetal, donor1	10073-102A1	8.58	3.00	2.57	0.00	0.00	0.00	0.00	0.00	0.43
occipital pole, adult, pool1	10036-101E9	6.47	10.56	2.92	0.24	0.00	0.00	0.00	0.00	0.32
olfactory region, adult	10195-103E6	9.17	10.13	1.91	0.57	0.00	0.00	0.00	0.19	0.00
optic nerve, donor1	10277-104E7	38.02	88.05	6.00	0.00	0.00	0.00	0.00	0.00	6.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	27.45	4.10	2.51	0.00	0.34	0.11	0.11	0.00	0.00
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	25.83	30.23	8.79	0.55	0.14	0.00	0.00	0.00	0.27
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	7.79	4.91	2.37	0.00	0.00	0.00	0.00	0.00	0.00
oral squamous cell carcinoma cell line:SAS	10544-107H4	20.33	5.54	4.85	0.58	0.12	0.12	0.00	0.12	0.12
osteoclastoma cell line:Hs 706.T	10704-109H2	75.55	26.75	11.17	0.88	0.29	0.00	0.00	0.00	0.29
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	42.98	2.80	4.67	0.00	0.00	0.00	0.00	0.00	0.93
osteosarcoma cell line:HS-Os-1	10558-107I9	18.24	12.30	4.88	0.42	0.00	0.00	0.00	0.00	0.42
ovary, adult, pool1	10020-101D2	24.72	4.37	4.63	0.17	0.35	0.00	0.44	0.17	0.26
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	53.35	16.50	10.82	0.73	0.92	0.00	0.00	0.37	0.55
pancreas, adult, donor1	10049-101G4	27.28	2.82	6.58	0.00	0.00	0.00	0.00	0.00	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	34.10	0.28	3.07	0.00	0.28	0.28	0.00	0.00	0.00
papillary adenocarcinoma cell line:8505C	10437-106E5	48.72	18.74	6.98	0.51	0.68	0.17	0.85	0.00	0.17
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	19.70	8.61	5.96	0.00	0.00	0.00	0.00	0.00	0.00
paracentral gyrus, adult, pool1	10035-101E8	7.87	11.53	2.84	1.10	0.09	0.00	0.00	0.00	0.00
parietal cortex, adult, donor10258	10373-105G4	8.81	4.40	0.73	0.00	0.73	0.00	0.00	0.00	0.00
parietal lobe - adult, donor10196	10171-103B9	4.70	14.11	0.94	0.00	0.00	0.00	0.00	0.00	0.94
parietal lobe, adult, donor10252	10157-103A4	19.10	22.52	3.71	1.14	0.00	0.00	0.29	0.29	0.29
parietal lobe, adult, pool1	10034-101E7	8.28	14.01	3.52	0.44	0.00	0.00	0.09	0.00	0.18
parietal lobe, fetal, donor1	10072-101I9	12.61	0.97	0.97	0.97	0.00	0.00	0.00	0.00	0.00
parietal lobe, newborn, donor10223	10356-105E5	8.97	3.74	4.49	0.00	0.00	0.00	0.37	0.00	1.12
parotid gland, adult	10199-103F1	8.02	1.23	1.85	0.00	0.00	0.00	0.00	0.00	0.00
penis, adult	10200-103F2	19.87	9.67	1.61	0.00	0.00	0.00	0.00	0.00	0.54
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	21.01	24.73	8.92	0.56	0.37	0.00	0.19	0.00	0.19
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	29.87	8.16	5.25	0.00	0.15	0.15	0.00	0.00	0.58
pineal gland - adult, donor10196	10179-103C8	7.74	1.94	0.65	0.00	0.00	0.00	0.00	0.00	0.00
pineal gland, adult, donor10252	10160-103A7	18.95	2.96	1.18	0.00	0.00	0.00	0.00	0.00	0.00
pineal gland, adult, donor10258	10377-105G8	10.03	0.63	0.00	0.00	0.00	0.00	0.00	0.00	0.00
pituitary gland - adult, donor10196	10180-103C9	27.32	3.04	6.07	0.00	0.00	0.00	0.00	0.00	1.01
pituitary gland, adult, donor10252	10162-103A9	51.60	2.61	5.21	0.00	0.00	0.00	0.00	0.00	0.00
pituitary gland, adult, donor10258	10378-105G9	28.94	1.70	3.40	0.00	0.85	0.00	0.00	0.00	0.00
placenta, adult, pool1	10021-101D3	57.73	6.24	5.91	0.43	0.32	0.22	0.54	0.22	0.32
plasma cell leukemia cell line:ARH-77	10840-111E3	12.05	0.26	0.53	0.00	0.13	0.13	0.00	0.00	0.00
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	37.20	15.41	4.67	0.16	0.31	0.16	0.31	0.00	0.31
pons, adult, pool1	10033-101E6	11.36	21.69	1.89	0.26	0.17	0.00	0.00	0.09	0.43
postcentral gyrus, adult, pool1	10032-101E5	10.29	12.73	2.35	0.44	0.00	0.00	0.09	0.09	0.61
promyelocytes/myelocytes PMC, donor1	12132-128D8	41.83	8.37	0.00	0.00	2.09	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	5.51	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	46.94	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	24.91	1.17	1.46	0.00	0.00	0.00	0.00	0.15	0.00
prostate cancer cell line:PC-3	10439-106E7	31.04	10.35	6.17	0.54	0.18	0.00	0.18	0.00	0.00
prostate, adult, pool1	10022-101D4	22.49	7.07	3.90	0.36	0.45	0.09	0.18	0.18	0.18
putamen, adult, donor10196	10176-103C5	6.61	7.08	1.89	0.47	0.00	0.24	0.00	0.00	0.00
putamen, adult, donor10252	10152-102I8	9.80	15.69	7.84	1.96	0.00	0.00	0.00	1.96	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	9.84	1.09	1.09	0.00	0.00	0.00	0.00	0.00	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	5.07	5.32	2.66	0.48	0.00	0.00	0.24	0.00	0.48
putamen, newborn, donor10223	10365-105F5	17.24	13.49	7.50	1.50	0.00	0.00	0.00	0.00	0.75
rectal cancer cell line:TT1TKB	10469-106I1	17.46	14.84	4.95	0.29	0.58	0.00	0.00	0.00	0.87
rectum, fetal, donor1	10067-101I4	16.69	18.08	1.39	0.00	0.00	0.00	0.00	0.00	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	41.76	10.60	11.66	0.21	0.42	0.21	0.00	0.00	0.00
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	67.93	15.74	8.70	0.00	0.00	0.41	0.41	0.00	0.00
retina, adult, pool1	10030-101E3	23.46	7.55	2.09	0.00	0.00	0.00	0.20	0.20	0.30
retinoblastoma cell line:Y79	10475-106I7	8.83	0.00	1.30	0.00	0.52	0.00	0.00	0.00	0.00
rhabdomyosarcoma cell line:KYM-1	10787-110H4	18.20	3.07	1.48	0.00	0.00	0.00	0.00	0.00	0.00
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	35.99	3.94	7.03	0.28	0.28	0.00	0.00	0.00	0.56
sacrococcigeal teratoma cell line:HTST	10695-109G2	34.86	9.09	6.06	0.00	0.76	0.00	0.00	0.76	0.00
salivary acinar cells, donor1	11771-123I7	25.41	5.34	3.08	0.00	0.00	0.32	0.00	0.00	0.16
salivary acinar cells, donor2	11772-123I8	22.86	4.13	1.93	0.00	0.14	0.00	0.28	0.00	0.00
salivary acinar cells, donor3	11773-123I9	18.54	2.65	0.66	0.00	0.00	0.00	0.00	0.00	0.00
salivary gland, adult, pool1	10093-102C3	8.01	1.72	1.14	0.00	0.00	0.00	0.00	0.00	0.00
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	41.48	9.02	5.40	0.34	0.67	0.00	0.00	0.00	0.25
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	38.79	8.46	4.23	0.00	0.59	0.00	0.24	0.24	0.47
seminal vesicle, adult	10201-103F3	40.21	3.17	4.23	0.00	0.53	0.53	0.00	0.53	0.00
serous adenocarcinoma cell line:JHOS-2	10639-108I9	6.07	1.70	0.73	0.00	0.00	0.00	0.24	0.00	0.00
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	14.85	3.52	2.01	0.00	0.00	0.00	0.00	0.00	0.25
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	28.10	5.02	5.02	0.00	0.00	0.00	0.00	0.00	1.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	59.37	2.15	3.76	0.27	0.13	0.00	0.00	0.00	0.13
signet ring carcinoma cell line:Kato III	10436-106E4	21.11	108.21	5.86	0.55	0.22	0.00	0.11	0.11	0.22
signet ring carcinoma cell line:NUGC-4	10483-107A6	19.35	65.16	4.39	0.26	0.52	0.00	0.13	0.00	0.52
skeletal muscle - soleus muscle, donor1	10282-104F3	7.80	1.42	2.84	0.00	0.00	0.71	0.00	0.00	0.00
skeletal muscle, adult, pool1	10023-101D5	15.59	1.20	3.24	0.00	0.24	0.00	0.36	0.00	0.00
skeletal muscle, fetal, donor1	10066-101I3	19.10	5.03	3.02	0.00	0.00	0.00	0.00	0.00	0.00
skin, adult, donor1	10074-102A2	0.00	13.57	0.00	0.00	0.00	0.00	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	27.77	5.68	5.05	0.00	0.00	0.00	0.00	0.00	0.00
small cell cervical cancer cell line:HCSC-1	10800-110I8	22.68	8.00	8.00	0.33	0.33	0.00	0.67	0.00	0.00
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	36.88	1.58	0.63	0.00	0.32	0.00	0.00	0.00	0.32
small cell lung carcinoma cell line:DMS 144	10841-111E4	24.29	2.12	3.85	0.00	0.00	0.19	0.00	0.00	0.19
small cell lung carcinoma cell line:LK-2	10541-107H1	27.20	9.72	3.13	0.16	0.33	0.00	0.00	0.00	0.16
small cell lung carcinoma cell line:NCI-H82	10842-111E5	13.51	1.29	2.90	0.00	0.16	0.00	0.00	0.00	0.16
small cell lung carcinoma cell line:WA-hT	10562-108A4	64.50	6.32	19.83	1.31	1.09	0.00	0.00	0.00	0.87
small intestine, adult, pool1	10024-101D6	29.14	32.01	4.78	0.48	0.48	0.12	0.36	0.24	0.48
small intestine, fetal, donor1	10064-101I1	7.13	9.58	4.91	0.00	0.00	0.25	0.00	0.00	0.00
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	206.19	50.26	42.57	1.54	1.54	0.00	1.03	0.00	0.00
smooth muscle, adult, pool1	10048-101G3	19.64	7.50	2.84	0.00	0.00	0.00	0.00	0.00	0.00
somatostatinoma cell line:QGP-1	10781-110G7	54.68	18.49	11.26	0.54	1.07	0.27	0.27	0.27	0.54
spinal cord - adult, donor10196	10181-103D1	14.45	36.70	3.67	0.92	0.00	0.00	0.00	0.00	0.92
spinal cord, adult, donor10252	10159-103A6	26.81	42.98	4.34	1.58	0.39	0.39	0.00	0.39	1.58
spinal cord, adult, donor10258	10369-105F9	8.99	5.53	4.15	1.38	0.00	0.00	0.00	0.00	0.00
spinal cord, fetal, donor1	10056-101H2	26.22	41.47	5.49	0.00	0.00	0.00	0.00	0.00	1.83
spinal cord, newborn, donor10223	10359-105E8	28.93	38.57	7.35	0.46	0.46	0.00	0.00	0.00	0.46
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	41.82	19.57	8.21	1.34	0.90	0.15	0.45	0.30	0.00
spleen, adult, pool1	10025-101D7	35.90	4.96	2.64	0.00	0.99	0.11	0.55	0.00	0.11
spleen, fetal, pool1	10044-101F8	34.09	9.30	3.65	0.16	0.48	0.08	0.00	0.00	0.16
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	34.88	2.38	2.59	0.21	0.41	0.00	0.00	0.00	0.10
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	27.15	2.47	0.95	0.00	0.00	0.00	0.00	0.19	0.00
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	14.33	0.35	1.75	0.35	0.00	0.00	0.00	0.00	0.00
squamous cell carcinoma cell line:T3M-5	10616-108G4	100.86	46.13	22.67	1.95	0.78	0.00	0.00	0.00	1.17
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	37.26	17.56	11.03	0.34	0.34	0.11	0.00	0.00	0.11
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	24.99	6.35	5.93	0.00	0.00	0.00	0.00	0.00	0.42
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	31.31	4.23	2.96	0.00	0.85	0.00	0.00	0.00	1.27
stomach, fetal, donor1	10062-101H8	10.68	5.34	1.07	0.00	0.00	0.00	0.00	0.00	1.07
submaxillary gland, adult	10202-103F4	11.96	2.28	0.57	0.00	0.00	0.00	0.00	0.00	0.57
substantia nigra - adult, donor10196	10178-103C7	0.00	54.27	0.00	0.00	0.00	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	27.21	63.14	9.14	3.32	0.00	0.21	0.00	0.42	2.28
substantia nigra, adult, donor10258	10371-105G2	4.66	6.72	2.59	0.52	0.00	0.00	0.00	0.00	0.52
substantia nigra, newborn, donor10223	10358-105E7	24.73	33.21	7.07	1.41	0.00	0.00	0.00	0.00	0.71
synovial sarcoma cell line:HS-SY-II	10441-106E9	18.11	9.40	9.86	0.69	0.00	0.00	0.46	0.00	1.38
temporal lobe, adult, pool1	10031-101E4	8.99	16.19	3.48	0.68	0.00	0.00	0.08	0.17	0.51
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	7.83	2.14	2.14	0.00	0.00	0.00	0.00	0.00	0.00
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	9.23	1.76	2.20	0.00	0.00	0.00	0.00	0.00	0.88
tenocyte, donor1	11763-123H8	68.77	24.79	11.17	0.00	0.00	0.00	0.35	0.70	0.70
tenocyte, donor2	11765-123I1	37.77	11.06	4.96	0.00	0.76	0.00	0.00	0.38	0.00
tenocyte, donor3	11768-123I4	41.89	21.13	8.15	0.37	0.00	0.00	0.74	0.00	0.74
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	15.64	2.38	5.44	0.00	0.00	0.00	0.00	0.00	0.17
teratocarcinoma cell line:NCR-G1	10798-110I6	21.12	1.70	5.70	0.00	0.15	0.15	0.31	0.00	0.15
teratocarcinoma cell line:PA-1	10807-111A6	20.92	1.55	4.49	0.31	0.15	0.00	0.00	0.00	0.15
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	26.91	6.22	4.32	0.51	0.51	0.00	0.00	0.13	0.38
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	41.98	8.70	6.81	0.00	0.38	0.00	0.38	0.00	1.13
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	31.63	13.09	6.76	0.87	0.98	0.00	0.00	0.11	0.76
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	25.08	8.14	6.84	1.63	0.33	0.00	0.00	0.00	0.33
testis, adult, pool1	10026-101D8	24.70	7.95	5.80	0.11	0.11	0.32	1.40	0.54	0.00
testis, adult, pool2	10096-102C6	12.18	2.71	2.26	0.00	0.00	0.00	0.00	0.00	0.90
thalamus - adult, donor10196	10168-103B6	11.04	33.12	4.42	1.10	0.00	0.00	0.00	0.00	2.21
thalamus, adult, donor10252	10154-103A1	27.19	57.36	6.41	2.66	0.16	0.00	0.47	0.16	0.63
thalamus, adult, donor10258, tech_rep1	10370-105G1	9.24	15.40	1.54	3.08	0.00	0.00	0.00	0.00	3.08
thalamus, adult, donor10258, tech_rep2	10370-105G1	10.21	13.50	2.80	0.82	0.00	0.16	0.16	0.00	0.49
thalamus, newborn, donor10223	10366-105F6	19.56	5.75	4.03	0.58	0.58	0.00	0.00	0.00	0.58
throat, adult	10209-103G2	12.23	3.00	1.00	0.25	0.00	0.00	0.00	0.00	0.25
throat, fetal, donor1	10061-101H7	18.28	7.01	1.22	0.00	0.00	0.30	0.00	0.00	0.00
thymic carcinoma cell line:Ty-82	10803-111A2	10.14	22.06	2.58	0.79	0.00	0.00	0.00	0.20	0.20
thymus, adult, pool1	10027-101D9	9.35	2.68	1.09	0.10	0.00	0.00	0.30	0.00	0.00
thymus, fetal, pool1	10043-101F7	15.38	3.32	1.66	0.00	0.00	0.00	0.10	0.00	0.21
thyroid carcinoma cell line:KHM-5M	10776-110G2	40.42	23.93	13.30	1.33	0.13	0.00	0.27	0.00	1.46
thyroid carcinoma cell line:TCO-1	10783-110G9	31.71	8.66	2.79	0.14	0.14	0.00	0.14	0.00	0.14
thyroid, adult, pool1	10028-101E1	34.53	4.85	4.20	0.09	0.19	0.09	0.09	0.00	0.56
thyroid, fetal, donor1	10060-101H6	28.21	3.16	1.58	0.00	0.00	0.00	0.00	0.00	0.00
tongue epidermis (fungiform papillae), donor1	10288-104F9	9.24	12.32	6.16	0.00	0.00	3.08	0.00	0.00	0.00
tongue, adult	10203-103F5	7.44	3.72	1.40	0.00	0.00	0.00	0.00	0.00	0.00
tongue, fetal, donor1	10059-101H5	12.22	2.36	2.76	0.00	0.39	0.00	0.00	0.00	0.39
tonsil, adult, pool1	10047-101G2	13.32	4.91	1.50	0.00	0.20	0.00	0.00	0.00	0.00
trachea, adult, pool1	10029-101E2	17.01	6.46	2.37	0.16	0.33	0.00	0.33	0.00	0.25
trachea, fetal, donor1	10058-101H4	19.62	9.23	1.54	0.00	0.00	0.00	0.00	0.38	0.00
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	43.22	21.61	12.40	0.00	0.00	0.35	0.35	0.00	1.06
transitional-cell carcinoma cell line:5637	10418-106C4	33.94	10.13	10.54	0.81	0.30	0.20	0.10	0.10	0.41
transitional-cell carcinoma cell line:JMSU1	10492-107B6	41.37	2.35	2.98	0.47	0.63	0.16	0.31	0.31	0.00
tridermal teratoma cell line:HGRT	10694-109G1	53.27	20.93	15.22	0.00	0.00	0.00	0.00	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	20.65	10.41	4.91	0.00	0.08	0.00	0.08	0.00	0.00
umbilical cord, fetal, donor1	10057-101H3	29.21	0.00	2.09	0.00	0.00	0.00	0.00	0.00	0.00
uterus, adult, pool1	10100-102D1	22.35	7.17	6.48	0.34	0.34	0.00	0.17	0.00	0.34
uterus, fetal, donor1	10055-101H1	27.64	7.68	11.77	0.00	0.51	0.00	0.00	0.00	0.00
vagina, adult	10204-103F6	36.19	42.65	6.46	0.00	0.65	0.00	0.65	0.65	0.65
vein, adult	10191-103E2	18.19	4.82	2.63	0.44	0.00	0.00	0.00	0.22	0.00
xeroderma pigentosum b cell line:XPL 17	10563-108A5	9.88	1.07	0.27	0.00	0.00	0.00	0.00	0.00	0.00